Cambridge Cognition 3 sector A4 mastheads · a succinct review of the existing literature relating...
Transcript of Cambridge Cognition 3 sector A4 mastheads · a succinct review of the existing literature relating...
2 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
About the authors
Cambridge Cognition is a leading global provider of computerized cognitive tests
combining neuroscience and technology to optimize mental health through life.
CANTAB, has become the worlds most validated and comprehensive cognitive
assessment system, used to conduct sensitive language-independent
touchscreen tests in pharmaceutical clinical trials and research projects for over 30 years.
UK office
Cambridge Cognition
Tunbridge Court
Bottisham
Cambridge
CB25 9TU United Kingdom
Copyright
The copyright in all material published in this handbook by Cambridge
Cognition, including all portions of the text, graphics and the selection and
arrangement of the material is owned by Cambridge Cognition, unless otherwise
indicated.
All rights reserved. The Material may not be reproduced or distributed, in whole
or in part, without prior written permission of Cambridge Cognition. However,
reproduction in part, by non-profit, research or educational institutions for their
own use is permitted if proper credit is given, with full citation, and copyright is
acknowledged. Any other reproduction or distribution, in whatever form and by
whatever media, is expressly prohibited without the prior written consent of
Cambridge Cognition. For further information, please contact:
+44 (0)1223 810 700
1 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Contents
Introduction .................................................................................. 2
An overview of CANTAB .................................................................. 2
Familiarisation .............................................................................. 5
Motor Screening Test (MOT) ........................................................... 5
Psychomotor speed ....................................................................... 6
Reaction Time (RTI) ....................................................................... 7
Attention ..................................................................................... 11
Rapid Visual Information Processing (RVP) ...................................... 11
Episodic memory ......................................................................... 17
Paired Associates Learning (PAL) ................................................... 18
Delayed match to sample (DMS) ................................................... 25
Working memory and executive function .................................... 30
Spatial Working Memory (SWM) .................................................... 31
Cognitive testing: test recommendation by disease .................... 38
Cognitive testing: quality consideration ...................................... 39
Study practicalities ..................................................................... 41
Data analysis considerations ....................................................... 43
2 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Introduction The CANTAB Cognition Handbook offers a comprehensive introduction to computerized cognitive assessment with CANTAB. It starts with an overview of CANTAB software, and then is divided into a series of sections that focus on the key cognitive domains of psychomotor speed, attention, episodic memory, working
memory and executive function.
Each section starts by providing an overview of the theoretical background to the cognitive domain and how it is affected in neurodegenerative, psychiatric and neurological
disorders. Each section then describes and discusses the CANTAB test or tests that have been used to assess the cognitive domain, with a succinct review of the existing literature relating to each CANTAB test included. Evidence is also integrated from pharmacological studies, studies of patients with Alzheimer’s disease
(AD), mild cognitive impairment (MCI), depression, schizophrenia and attention deficit hyperactivity disorder (ADHD) as well as data from neuroimaging research to provide a convergent overview of the use and
interpretation of the CANTAB tests.
The text concludes with general information on study design, study practicalities and data analysis considerations, making this a useful resource at all stages of studies using CANTAB. It is likely to be of interest not only to psychologists and neuroscientists, but also to
anyone with an interest in using theoretically motivated and empirically validated cognitive tests in their research.
An overview of CANTAB
The Cambridge Neuropsychological Test
Automated Battery (CANTAB) is composed of 25
tests and was created at the University of
Cambridge in the 1980s. CANTAB has been in
continuous development for over two decades.
CANTAB has established sensitivity to a large
number of drugs and disorders and has been
extensively validated. To date, CANTAB has
been cited in over 1500 peer-reviewed articles
(http://www.cantab.com/cantab/site/bibliograp
hy.acds).
CANTAB tests were designed to be independent
of language and culture, which makes them
ideal for use in multi-national studies. The
battery has been used in 50 countries in
academic research and in multi-national clinical
trials.
Due to the nature of the CANTAB tests, pre-
baseline participant training is not required,
which reduces the time taken up by cognitive
testing in your trial. There are instead built-in
practice phases at the start of tests that allow
participants to familiarize themselves with the
tasks. A simple motor screening test is also used
to familiarize participants with the system and
to ensure that they are able to follow
instructions and use the touch screen
accurately.
Most CANTAB tests are graded in difficulty and
as a result have been used to test highly
impaired patients as well as high-functioning
individuals. CANTAB tests have excellent test-
retest reliability and parallel forms to help guard
against learning effects over repeated testing
sessions.
This guide introduces you to the key cognitive
domains assessed by CANTAB and the measures
used to interpret the data. For each test, there
is a summary of some of the key findings
relating to imaging, pharmacological and clinical
studies. At the end of the manual we provide an
overview of general testing and data analysis
considerations when using CANTAB.
Cognitive domains
Sound understanding of the complexities of
cognitive function is needed in order to
overcome the challenge of reliable assessment.
IQ tests provide one way of measuring
intellectual functioning. However, despite being
undoubtedly useful and important, IQ tests only
provide a broad and static profile of what we
mean by ‘cognition’. Furthermore, some
intelligence tests, particularly those based on
verbal knowledge, are relatively insensitive to
impairments such as those seen in early
Alzheimer’s disease.
3 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Cognitive neuroscience now divides cognition
into different neural systems controlling, for
example, aspects of perception, attention,
short-term memory, working memory, long
term memory (e.g. facts and personal
episodes), language and executive functions,
such as planning, decision-making and impulse
control. These different processes work together
to gather, store and make sense of information
from the environment, and use these
representations to guide the production of
thoughts and behaviour.
Any comprehensive battery of cognitive tests
should provide an overview of these different
stages of behaviour, starting at the most basic.
For cognition to occur at all, there must be
evidence of normal sensory or motor
functioning; if the information does not reach
the brain or cannot be expressed by it, then
clearly cognitive functioning cannot be
accurately assessed.
Four main domains of function are assessed in
CANTAB: psychomotor speed (page 5),
attention (page 11), memory (page 17) and
executive function (page 30). Together, these
domains provide a comprehensive assessment
of different levels of cognitive processing.
Each of these cognitive domains relies on a
distinct but overlapping set of brain areas. They
are therefore differentially affected by age,
disease and pharmacological manipulation.
Combined with brain imaging methodologies,
many of the CANTAB tests have also been shown
to be useful for defining the specific network of
brain structures responsible for their
performance (e.g. the prefrontal cortex, parietal
lobe and striatum in the case of visuospatial
planning). Correspondingly, a failure on a task
may suggest some form of impairment in that
specific brain system.
Cognition in central nervous system (CNS) disease
For each section we provide a brief overview of
CANTAB data in a range of neurodegenerative,
psychiatric and neurological disorders, which
provide an indication of the sensitivity of the
tests to impairment in clinical populations and
sensitivity to treatment effects. The core
disorders on which we focus are:
AD/MCI
Depression
Schizophrenia
ADHD
AD/MCI
Alzheimer’s disease (AD) and mild cognitive
impairment (MCI) are characterised by an
insidious onset with progressive cognitive
decline. The earliest cognitive impairment is
episodic memory. As the disease progresses,
cognitive deficits become more global and
include impairments in attention, semantic
memory and executive function (reasoning,
planning and cognitive flexibility). Cognitive
deficits reflect damage to the basal forebrain
resulting in loss of acetylcholine throughout the
cortex and especially the temporal cortex.
Cognitive decline is one of the clinical hallmarks
of MCI/AD. Cognition is consequently a key
outcome measure in any trials testing new
products aimed at halting or even preventing the
progression of AD pathology.
• Égerházi, A., Berecz, R., Bartók, E., & Degrell,
I. (2007). Automated Neuropsychological Test
Battery (CANTAB) in mild cognitive
impairment and in Alzheimer's disease.
Progress in Neuro-Psychopharmacology and
Biological Psychiatry, 31(3), 746-751.
• Fowler, K.S. et al. (2002). Paired associate
performance in the early detection of DAT.
Journal of the International
Neuropsychological Society.
Depression
Major depressive disorder is characterised by
depressed mood and/or loss of interest or
pleasure in life activities, causing clinically
significant impairment in social life, work, or
other important areas of every day functioning.
4 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
The disorder is typically associated with deficits
of varying severity across a range of cognitive
functions including attention, working memory
and executive function, particularly on tests that
require effortful processing. A further cognitive
hallmark of the disorder is a negative bias in the
interpretation of (and memory for) emotionally-
salient information. Some cognitive symptoms
persist even in remitted individuals while others
are present predominantly during acute phases
and may increase in severity with progression of
the illness.
• Rock, P.L., Roiser, J.P., Riedel, W.J. &
Blackwell, A. D. (2013). Cognitive impairment
in depression: a systematic review and meta-
analysis. Psychological Medicine
Schizophrenia
Schizophrenia is characterised by widespread
cognitive dysfunction (affecting attention, visual
and verbal memory, executive function and
social cognition) in addition to positive and
negative symptoms. Cognitive Impairment
Associated with Schizophrenia (CIAS) is an
important determinant of functional outcome
and is inadequately treated by antipsychotic
medication, and thus represents a major target
for novel therapeutics.
Barnett, J. H., Robbins, T. W., Leeson, V. C.,
Sahakian, B. J., Joyce, E. M., & Blackwell, A. D. (2010). Assessing cognitive function in clinical trials of schizophrenia. Neuroscience & Biobehavioral Reviews, 34(8), 1161-1177.
ADHD
Attention deficit hyperactivity disorder (ADHD)
is a neurodevelopmental disorder characterised
by symptoms of inattention, hyperactivity,
and/or impulsivity that interfere with the
everyday functioning of affected patients. While
it predominantly affects children and
adolescents, some patients continue to
experience persistent symptoms at adulthood,
which often leads to high unemployment rates
and drug abuse if left untreated.
Understanding how ADHD and its treatment
affect cognitive function has clear implications
for the diagnosis and management of this
condition.
• Chamberlain, S. R., Robbins, T. W., Winder-
Rhodes, S., Müller, U., Sahakian, B. J.,
Blackwell, A. D., & Barnett, J. H. (2011).
Translational approaches to frontostriatal
dysfunction in attention-deficit/hyperactivity
disorder using a computerized
neuropsychological battery. Biological
psychiatry, 69(12), 1192-1203.
Cognitive testing in non-CNS disorders
There is a growing recognition that cognition is
a potentially important endpoint for researchers
interested in a range of diseases and
interventions which do not directly target the
central nervous system, but which nevertheless
may affect cognitive function.
Although the brain is quite well-protected from
many blood-borne chemicals by the blood-brain
barrier, many small molecules, including agents
that may be therapeutic for illnesses affecting
other organs, may be deleterious to brain
function. Examples include environmental
chemical drugs used to treat cancer, asthma,
high cholesterol, cardiovascular problems,
diabetes, and drugs that affect the immune
system.
Virtually all effective drugs have some ‘adverse
side-effects’. These can be the product of a
drug’s non-specific mechanisms of action or may
simply reflect effects at other receptors distal
from the therapeutic target. Many of these side
effects are not serious. Other effects, such as
sedation, represent a clear cost but have to be
set against the major benefits of medication.
However, other actions, which may be insidious,
can in the long-term be so disadvantageous that
the treatment has to be discontinued. All of
these issues have to be considered during the
initial screening of new compounds or trials
involving them, as well as research studies that
investigate the repurposing of compounds for
new indications.
5 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Disturbances of normal homeostasis can also
result in undesirable effects on cognition if the
supply of nutrients and oxygen required for
cognitive function is disrupted. Because of the
impact of potential treatments for non-CNS
disorders on cognition, there is increasing
interest in assessing cognitive function in these
areas. Desirable features of cognitive tests for
the purpose of testing the safety of compounds
include sensitivity to disease and
pharmacological manipulation. This makes
CANTAB well suited to such studies, this guide.
General references and introduction to CANTAB tests
• Clark, L., Boxer, O., Sahakian, B. J., & Bilder,
R. M. (2012). Research methods: cognitive
neuropsychological methods. Handbook of
clinical neurology, 106, 75.
• Levaux, M. N., Potvin, S., Sepehry, A. A.,
Sablier, J., Mendrek, A., & Stip, E. (2007).
Computerized assessment of cognition in
schizophrenia: promises and pitfalls of
CANTAB. European Psychiatry, 22(2), 104-
115.
• Parsey, C. M., & Schmitter-Edgecombe, M.
(2013). Applications of Technology in
Neuropsychological Assessment. The Clinical
Neuropsychologist, 27(8), 1328-1361.
• Robbins, TW, James, M, Owen, AM, Sahakian,
BJ, Lawrence, AD, McInnes, L & Rabbitt, PM
(1998) A Study of Performance on Tests from
the CANTAB battery Sensitive to Frontal Lobe
Dysfunction in a Large Sample of Normal
Volunteers: Implications for Theories of
Executive Functioning and Cognitive Aging.
Journal of the International
Neuropsychological Society, 4, 474-490, 1998
• Robbins, TW, James, T, Owen, AM, Sahakian,
BJ, McInnes, L & Rabbitt, PM (1994) CANTAB:
A Factor Analytic Study of a Large Sample of
Normal Elderly Volunteers. Dementia, 5, 266-
281.
Familiarisation
Motor Screening Test (MOT)
The MOT is used to perform familiarisation and
screening, and provides a simple reaction time
measure. The goal of the MOT is not primarily to
assess cognition but to provide a general
indication that psychomotor function is intact
enough to proceed with more sophisticated
cognitive testing.
On this test, a lack of drug or group effect should
be interpreted as indicating that any effects
identified on the rest of the CANTAB battery are
not confounded by general effects of the drug or
disease state on motor control or low level
perception.
In addition, it allows researchers to screen for
any problems with vision, movement or
language comprehension that may prevent the
participant from responding meaningfully to the
subsequent tasks. For this reason, it is
recommended that it be administered first.
Test Description
The Motor Screening test (MOT) is a task
designed to familiarise participants with the
touch screen and computer. The procedure
consists of a series of crosses shown in different
locations on the screen. The participant is asked
to touch each cross using the forefinger of the
dominant hand.
The test takes approximately 1 minute to
complete.
Psychomotor Speed
CANTAB Motor Screening Task
6 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
The ability to receive, process and respond to
input from the environment in an efficient way
is essential for effective functioning, particularly
in situations such as driving when rapid decision
making and response are critical for safety. The
concept of psychomotor speed encompasses a
component of both physical movement and
mental processing speed. Slowing in either one
of these aspects can result in an increase of
reaction times. It has been suggested that
slower speed and processing underlie decreases
in cognitive functioning with age associated with
neurodegenerative processes.
One of the key features of Parkinson’s disease is
slowing: this encompasses both motor slowing
and cognitive slowing. Other conditions, such as
depression and traumatic brain injury (TBI), are
also associated with reductions in psychomotor
speed, as are some drug effects.
Importantly, interpreting performance on more
complex tests of psychomotor speed relies on
intact performance at this more basic level of
processing.
Key references: • Robbins, T. (2002). The 5-choice serial
reaction time task: behavioural pharmacology
and functional neurochemistry.
Psychopharmacology, 163(3-4), 362-380.
• Salthouse, T. A. (1996). The processing-
speed theory of adult age differences in
cognition. Psychological review, 103(3), 403.
7 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Reaction Time Test (RTI)
Several CANTAB tests have an element of
processing speed, requiring participants to
respond as quickly as possible. RTI makes
response speed the focus of the task. The
structure of the task enables slowing in
movement to be dissociated from slowing in
cognitive processing. In addition, by increasing
the number of items the participant has to
monitor (from 1 to 5 circles), the cognitive load
of the task can be increased, thereby placing
heavier demands on attention.
Description of the test
RTI is a measure of simple and choice reaction
time, movement time and vigilance during
simple and 5-choice reaction time trials. This
task also permits measurement of
anticipatory/premature responding and
perseverative responding.
The participant must hold down a button until a
yellow spot appears on the screen, at which
point they must touch the yellow spot as quickly
as they can. The spot appears in a single location
during the simple reaction time phase and in one
of five locations in the 5-choice reaction time
phase.
Core outcomes
Key
Outcome
Measures
Definition
Median
Simple or 5-
choice
reaction
time
The median duration between the
onset of the stimulus and the time at
which the subject released the
button. This measure is calculated
from correct, assessed trials in which
the stimulus could appear in one
location only / any one of five
locations
Median
Simple or 5-
choice
movement
time
The median time taken to touch the
stimulus after the button has been
released. This measure is calculated
from correct, assessed trials where
stimuli could appear in one location
only / any one of five locations
CANTAB Reaction Time test
8 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Brain systems
Reaction time and attention are dependent on a
network of brain areas including the prefrontal
and parietal lobes, and are also dependent on
neurotransmitter release from mid-brain
structures such as the nucleus accumbens and
ventral tegmental area.
Pharmacological manipulations
The CANTAB RTI task is a direct analogue of the
rodent 5-choice serial reaction time test (5-
CSRT), one of the most well-studied animal
behaviour paradigms. In the rat, 5-CSRT shows
sensitivity to discrete lesion sites in the
prefrontal cortex, to cholinergic lesions in basal
forebrain (e.g. McGaughy, Dalley, Morrison,
Everitt, & Robbins, 2002), and to several classes
of compound. In humans, the CANTAB RTI test
shows differential pharmacological sensitivity.
For example, clonidine, but not guanfacine,
impairs five-choice reaction time performance in
young healthy volunteers (Jäkälä et al, 1999).
Age effects
With increasing age there is a gradual but
significant decrease in processing speed (Figure
1).
Sensitivity to impairment in clinical populations
Dementia and MCI
Alzheimer’s Disease (AD)
Cholinergic dysfunction is evident in Alzheimer’s
disease. This led to the prediction that this task
would demonstrate impairment in AD, and this
has now been demonstrated. For instance,
Swainson (2001) compared performance on
CANTAB tests in AD to that of a non-demented,
clinical population (patients with depression)
and a group of patients with ‘questionable
dementia’ (QD). They found that both AD and
QD subjects were impaired on the memory
tests. However, only the AD patients showed
impairment in both accuracy and latency in the
RTI test. Decline on the mini-mental state exam
(MMSE) was also found to correlate significantly
with choice reaction time.
A more recent study has confirmed these
findings. In a study which compared
performance of AD patients to those with Mild
Cognitive Impairment (MCI) and normal
controls, Saunders and Summers (2010) found
that the AD group was significantly slower on
choice reaction time than the all the other
groups. Significant slowing was also seen on the
simple reaction time measure in amnestic MCI
(a-MCI) and AD groups, with the AD group also
being significantly slower than the a-MCI group.
A pharmacological study of the cholinesterase
inhibitor tacrine in AD patients found that while
there was no significant effect on tests of
memory (e.g. PAL or DMTS), there was a
significantly beneficial effect on accuracy and
latency in RTI performance (Sahakian et al.,
1993). This suggests that the deficits seen in AD
are attributable to the alterations in cholinergic
neurotransmission in this disease.
Mild Cognitive Impairment (MCI)
The data from studies which have examined MCI
alongside AD and normal ageing (e.g. Swainson
2001; Saunders and Summers, 2010), reviewed
briefly above, suggest that there are no, or
limited, differences between controls and MCI
Figure 1: Age related impairments in reaction time. Data
are expressed as mean ± SEM. N=250
9 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
patients in reaction time measures. This has
been confirmed by studies which have focused
on subtypes of MCI (e.g. Klekociuk & Summers
2014a, 2014b).
However, at longitudinal follow-up of 10 and 20
months, a-MCI groups showed significant
slowing in both simple and choice reaction time.
This significant slowing was not observed in
control or non-amnestic MCI participants
(Saunders and Summers, 2011). It is unclear
whether this increase in slowing with time
represents part of a trajectory to dementia in
this MCI group. However, such impairment
seems to occur relatively late compared to
deficits in episodic memory (e.g. PAL).
Psychiatric and mood disorders
Depression
Depressed individuals frequently report
cognitive slowing as a symptom. Despite this, a
recent meta-analysis of cognitive function in
depression showed that there was no significant
impairment in RTI in currently depressed
patients (Rock et al., 2013), although some
authors have reported an improvement in
psychomotor speed during remission (Egerhazi
et al., 2013).
Schizophrenia
Impairments in reaction time are frequently
observed in schizophrenia. These tend to be
marked and are present even in medication-
naïve cases with first-episode schizophrenia
(Fagerlund et al., 2004).
Deficits are still present, but are not as profound
in early-onset schizophrenia (Fagerlund et al.,
2006). Interestingly, a longitudinal study of
early onset-schizophrenia demonstrated
significant impairment in both reaction times
and movement times relative to controls.
However, over five year follow-up there was no
significant worsening in the severity of this
impairment (Jepsen et al., 2010), suggesting
that this is an aspect of cognition which is
differently affected in early onset schizophrenia,
and remains relatively stable in this group.
Neurological and movement disorders
ADHD
Attentional processing is a core deficit in ADHD.
Consistent with this, impairments have been
observed in children with ADHD. For instance,
Gau and Huang (2013) compared both children
with ADHD and their unaffected siblings to
typically developing controls. They found that
those with ADHD performed worse in the RTI
task after controlling for sex, age, co-morbidity,
parental educational levels and IQ.
Traumatic Brain Injury (TBI)
Processing speed and psychomotor slowing are
constantly reported in studies of TBI. Parry et al
(2004) reported that the mean performance of
their TBI group was significantly poorer than
that of their control group on all measures
derived from the RTI, including the simple
reaction time, simple movement time, 5-choice
reaction time and the 5-choice movement time.
Performance of both TBI and control participants
was correlated with metabolite concentration on
magnetic resonance spectroscopy, indicating a
relationship between indices of reaction time
and brain structural integrity.
Sterr at el. (2006) demonstrated that CANTAB
RTI was significantly impaired in patients with
symptomatic TBI relative to non-symptomatic
TBI patients and healthy controls, and that there
was a significant correlation between RTI speed
and accuracy and the severity of post-
concussion symptoms, suggesting that the task
is sensitive to clinically meaningful indices of TBI
severity.
Parkinson’s Disease (PD)
A 2004 study of RTI in PD patients found slowing
of movement in patients off medication, but not
on medication (Fern-Pollak 2004). However, an
earlier study examining RTI across a range of
disease severity found that deficits in reaction
time and accuracy increased as the severity of
PD increased (Riekkinen et al., 1998).
10 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Furthermore, withdrawal of dopaminergic
medication had a differential effect on reaction
time, depending on the severity of the
Parkinson’s disease, with those with the most
severe PD showing the largest effect on reaction
time. Choice reaction time performance has
been found to be a significant predictor of
freezing of gait, an important motor feature of
PD (Shine et al., 2012).
References • Egerhazi, A., Balla, P., Ritzl, A., Varga, Z.,
Frecska, E., & Berecz, R (2013). Automated
neuropsychological test battery in
depression–preliminary data.
Neuropsychopharmacol. Hung, 15, 5-11.
• Fagerlund, B., Mackeprang, T., Gade, A.,
Hemmingsen, R., & Glenthoj, B. Y. (2004).
Effects of low-dose risperidone and low-dose
zuclopenthixol on cognitive functions in first-
episode drug-naive schizophrenic
patients. CNS spectrums, 9, 364-374.
• Fagerlund, B., Pagsberg, A. K., &
Hemmingsen, R. P. (2006). Cognitive deficits
and levels of IQ in adolescent onset
schizophrenia and other psychotic disorders.
Schizophrenia research, 85(1), 30-39.
• Fern-Pollak, L., Whone, A. L., Brooks, D. J., &
Mehta, M. A. (2004). Cognitive and motor
effects of dopaminergic medication
withdrawal in Parkinson’s
disease. Neuropsychologia, 42(14), 1917-
1926.
• Gau, S. F., & Huang, W. L. (2014). Rapid
visual information processing as a cognitive
endophenotype of attention deficit
hyperactivity disorder. Psychological
medicine, 44(02), 435-446.
• Jakala P., Riekkinen M., Sirvio J., Koivisto E.,
Riekkinen P. JR, (1999) Clonidine, but not
guanfacine, impairs choice reaction time
performance in young healthy volunteers.
Neuropsychopharmacology, 21, 495-502
• Jepsen, J. R. M., Fagerlund, B., Pagsberg, A.
K., Christensen, A. M. R., Nordentoft, M., &
Mortensen, E. L. (2010). Deficient maturation
of aspects of attention and executive functions
in early onset schizophrenia. European child &
adolescent psychiatry, 19(10), 773-786. • Klekociuk, S. Z., & Summers, M. J. (2014a).
Exploring the validity of mild cognitive
impairment (MCI) subtypes: Multiple-domain
amnestic MCI is the only identifiable subtype
at longitudinal follow-up. Journal of Clinical
And Experimental Neuropsychology, 36(3),
290-301.
• Klekociuk, S. Z., & Summers, M. J. (2014b).
Lowered performance in working memory and
attentional sub‐processes are most prominent
in multi‐domain amnestic mild cognitive
impairment subtypes. Psychogeriatrics,
14(1), 63-71.
• McGaughy, J., Dalley, J. W., Morrison, C. H.,
Everitt, B. J., & Robbins, T. W. (2002).
Selective behavioral and neurochemical
effects of cholinergic lesions produced by
intrabasalis infusions of 192 IgG-saporin on
attentional performance in a five-choice serial
reaction time task. The Journal of
neuroscience, 22(5), 1905-1913.
• Parry, L., Shores, A., Rae, C., Kemp, A.,
Waugh, M. C., Chaseling, R., & Joy, P. (2004).
An investigation of neuronal integrity in
severe paediatric traumatic brain injury. Child
Neuropsychology, 10(4), 248-261.
• Riekkinen, M., Kejonen, K., Jakala, P.,
Soininen, H., & Riekkinen, P. (1998).
Reduction of noradrenaline impairs attention
and dopamine depletion slows responses in
Parkinson’s disease. European Journal of
Neuroscience, 10, 1449-1435.
• Rock, P. L., Roiser, J. P., Riedel, W. J., &
Blackwell, A. D. (2013). Cognitive impairment
in depression: a systematic review and meta-
analysis. Psychological medicine, 1-12.
• Sahakian, B. J., Owen, A. M., Morant, N. J.,
Eagger, S. A., Boddington, S., Crayton, L., ...
& Levy, R. (1993). Further analysis of the
cognitive effects of tetrahydroaminoacridine
(THA) in Alzheimer's disease: assessment of
attentional and mnemonic function using
CANTAB. Psychopharmacology,110(4), 395-
401.
• Saunders, N. L., & Summers, M. J. (2011).
Longitudinal deficits to attention, executive,
and working memory in subtypes of mild
cognitive impairment.
Neuropsychology, 25(2), 237.
• Saunders, N.J, & Summers M.J. (2010)
Attention and working memory deficits in mild
cognitive impairment. Journal of Clinical and
Experimental Neuropsychology 32(4), 350-
11 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
357.
• Shine, J. M., Moore, S. T., Bolitho, S. J.,
Morris, T. R., Dilda, V., Naismith, S. L., &
Lewis, S. J. G. (2012). Assessing the utility of
freezing of gait questionnaires in Parkinson’s
disease. Parkinsonism & related
disorders, 18(1), 25-29.
• Sterr, A., Herron, K. A., Hayward, C., &
Montaldi, D. (2006). Are mild head injuries as
mild as we think? Neurobehavioral
concomitants of chronic post-concussion
syndrome. BMC neurology, 6(1), 7.
• Swainson, R., Hodges, J. R., Galton, C. J.,
Semple, J., Michael, A., Dunn, B. D., ... &
Sahakian, B. J. (2001). Early detection and
differential diagnosis of Alzheimer’s disease
and depression with neuropsychological
tasks. Dementia and geriatric cognitive
disorders, 12(4), 265-280.
Attention
Attention can be seen as a gateway for
information into the other cognitive domains,
regulating the access of information from both
external (perceptual) and internal (memories,
knowledge) sources to later processing and
storage stages. The analogy that is frequently
used to describe attention is that of a spotlight
– an area or object where processing resources
are concentrated, sometimes at the expense of
items outside the focus of attention. Attention is
a limited resource which weakens as the number
of items over which it is shared increases.
Attention can also be characterised on the basis
of its temporal characteristics. When asked to
maintain attention over a long time, fatigue or
boredom sets in and accuracy can be
compromised. The capacity to resist distraction
and maintain the focus of attention in the face
of distracting information is referred to as
“selective attention”, while the ability to
maintain a steady level of attention over time is
referred to as “sustained attention”.
Attention depends on a broad network of areas
in the frontal and parietal lobes, including the
dorsolateral prefrontal cortex and the anterior
cingulate. Frontal regions are thought to be
particularly critical in guiding the goal-directed
allocation of attentional resources. In addition,
subcortical structures such as the pulvinar and
the superior colliculus are involved in the shifting
of attention.
Consistent with this widespread anatomical
network, multiple neurochemical systems are
implicated. Noradrenaline, acetylcholine and
dopamine all interact in complex ways to
modulate the shifting, maintenance and control
of attention.
Disruption to the spatial characteristics of
attention can be most clearly seen in the
example of unilateral neglect following a stroke
that affects the parietal lobes. This results in a
“bias” away from one half of space or one half of
an object, such that the patient does not report
items in the neglected side. Disruption to the
temporal characteristics of attention is a
hallmark of ADHD, where mind-wandering and
poor classroom performance are attributed
particularly to deficits in sustained attention.
Key references • Fried, R., Hirshfeld-Becker, D., Petty, C.,
Batchelder, H., & Biederman, J. (2012). How
informative is the CANTAB to assess
executive functioning in children with ADHD?
A controlled study. Journal of attention
disorders. • Klinkenberg, I., Sambeth, A., & Blokland, A.
Brain. (2011). Acetylcholine and
attention. Behavioural research, 221(2), 430-
442.
• Raz, A., & Buhle, J. (2006). Typologies of
attentional networks. Nature Reviews
Neuroscience, 7(5), 367-379.
Rapid Visual Information Processing Test (RVP)
While the RTI task provides an estimate of
vigilance, RVP assesses more complex aspects
of attention. In addition to the requirement to
respond accurately and quickly to a target,
participants have to discriminate what is and is
12 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
not a target in a rapidly changing stimulus array.
This heavily taxes sustained and selective
attention as well as processing speed.
The A-Prime (A’) outcome measure is based on
signal detection theory, and provides a single
index of how good a participant is at detecting a
target against ongoing distraction.
Description of the test
RVP is a test of continuous performance and
visual sustained attention. In a white box in the
centre of the screen, single digits appear in a
pseudo random order at a rate of 100 digits /
minute. Participants must detect a series of
target sequences (for example, 2,4,6; 4,6,8;
3,5,7) and register responses by touching
button. Nine target sequences appear every 100
numbers.
Core outcomes
Key Outcome
Measures
Definition
A-Prime A’ (A prime) is the signal detection measure of sensitivity to the target,
regardless of response tendency (the
expected range is 0.00 to 1.00; bad to good). In essence, this metric is a measure of how
good the subject is at detecting target sequences
Median latency The median response latency during assessment sequence
blocks where the subject responded correctly
CANTAB Rapid Visual Information Processing test
PFC
pSMA
ACC
PPC
Figure 2: Key anatomical and neurotransmitter
systems involved in attention and attentional control.
Attention depends on at least three separate yet
interacting neurotransmitter systems: noradrenaline
(blue), acetylcholine (yellow) and dopamine (green).
These modulate the activity of regions involved in
attentional and cognitive controls, such as the
prefrontal cortex (PFC), anterior cingulate (ACC),
pre-supplementary motor area (pSMA) and posterior
parietal (PPC) regions.
13 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Brain systems
Performance on the RVP task is associated with
activation in a network of brain structures,
including the frontal and parietal lobes (Coull et
al., 1995). RVP activates the classic fronto-
parieto-occipital “attentional” network (Figure
3).
Pharmacology
RVP is sensitive to a range of sedating and
stimulant effects (see Chamberlain et al., 2011
for a systematic review). For example,
performance is worsened by diazepam (Coull et
al., 1995) and improved by nicotine (Sahakian
et al., 1989). Methylphenidate reduces response
latencies on this task in healthy young
volunteers (Elliott et al., 1997), but does not
affect performance in healthy elderly males
(Turner et al., 2003).
RVP is sensitive to monoamine manipulations,
including clonidine (Coull et al., 1995). Dietary
depletion of the dopamine precursor tyrosine
impaired RVP performance in recovered
depressed patients compared to patients treated
with a balanced amino acid mixture (Roiser et
al., 2005). While stimulants can increase the
rate of commission errors on this task,
methylphenidate has been found to improve
performance in adults with ADHD (Turner et al.,
2005). Nicotine improves performance in
healthy volunteers and patients with Alzheimer’s
disease (Jones et al., 1992).
Ageing
With age, there is a reduction in the speed and
accuracy of processing.
Sensitivity to impairment in clinical populations
AD and MCI
Alzheimer’s disease
A number of different studies have
demonstrated impairment in RVP in patients
with Alzheimer’s disease. Swainson et al (2001)
compared four groups of patients: controls,
patients with AD, a group with ‘questionable
dementia’ (QD) and a group of depressed
patients. Both AD and QD subjects showed
impairments in latency and accuracy on RVP. A
more recent study demonstrated that RVP
latency was significantly longer in AD compared
to controls. However, there were no significant
differences between MCI and AD (Saunders and
Summers, 2010).
Pharmacological studies have demonstrated
deficits in accuracy and latency in RVP at
baseline in AD patients relative to controls.
These deficits were ameliorated in a dose-
dependent manner by the administration of
nicotine (Sahakian et al., 1989; Jones et al.,
1992).
Mild cognitive impairment
Individuals with MCI have been found to have
significantly worse performance on the RVP task
compared to controls (Klekociuk & Summers
2014c; Saunders and Summers 2011), with
some differences between amnestic and non-
amnestic MCI in terms of latency and accuracy
indices (Klekociuk & Summers 2014b), and no
significant difference between MCI and early AD
(Saunders and Summers 2010).
In terms of differentiating MCI from normal
ageing, RVP latency and accuracy were two of
ten significant predictors which could be used to
correctly identify participants with MCI from
Occipital cortex
DLPFC / IFG
Parietal
cortex
Figure 3: Activation of a fronto-parietal network of areas
during performance of the RVP task (Coull et al., 1995)
14 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
normal controls with a sensitivity of 80.0% and
a specificity of 87.9% (Klekociuk et al., 2014C).
However, longitudinal analysis has not
demonstrated a steady decline in performance
over a 10 and 20 month follow-up in patients
with MCI. Indeed, there is some evidence for
improved performance over time in some
individuals (Klekociuk & Summers 2014a).
Psychiatric and mood disorders
Depression
Patients with bipolar disorder are impaired on
RVP during both manic and remitted states
(Clark et al., 2001, 2002). In major depressive
disorder (MDD), some degree of sustained
attention impairment is present during
depressive phases, but these impairments
appear to recover completely during euthymia
(Clark et al., 2005).
A recent meta-analysis of studies of depressed
participants which have used CANTAB showed
that there was a significant deficit in RVP relative
to controls. This impairment was present even
in unmedicated and remitted participants (Rock
et al., 2013).
Schizophrenia
Deficits in patients with schizophrenia have been
reported in a number of studies. Prouteau et al.
(2004) explored the pattern of associations
between visual cognitive performance and
community functioning in patients with
Schizophrenia. They found that RVP
performance was associated with global
function, adjustment to living and behavioural
problems.
In addition to deficits in schizophrenia,
reductions in performance on CANTAB tests
including RVP were observed during the
prodromal phase of the disease (Bartók et al.,
2005). The authors concluded that deficits in
attention and cognition were present at the early
stages of development of psychosis and that
CANTAB might be a useful tool for early
detection in patients at risk of developing
schizophrenia.
Neurological and movement disorders
Traumatic brain injury
Numerous studies have shown that sustained
attention is impaired in patients with TBI (Chan,
2005; Malojcic et al., 2008; Parry et al., 2004).
For example, Salmond et al. (2005)
demonstrated that TBI patients exhibited
significantly longer response times and reduced
levels of target detection on CANTAB RVP
compared with healthy controls. The ecological
validity of the task is supported by findings such
as those of Sterr et al. (2006), who
demonstrated that performance on CANTAB RVP
was significantly associated with symptom
severity.
Multiple Sclerosis
Deficits in sustained attention are also observed
in MS, where participants with relapsing-
remitting MS (N=29) have slower response
latencies on the RVP (Roque et al., 2011).
ADHD
Attentional deficits, particularly the ability to
sustain attention, are a core deficit in ADHD.
Consistent with this, sustained attention
performance on RVP is significantly impaired in
ADHD (Turner et al., 2005, 2004). Gau and
Huang (2013) studied attentional performance
in typically developing controls, children with
ADHD and their unaffected siblings. They found
that, compared with controls, both children with
ADHD and their unaffected siblings had
significantly higher total misses and a lower
probability of hits in the RVP task. Deficits in
sustained attention were associated with a
longer duration of methylphenidate use and IQ,
but psychiatric co-morbidity and current use of
methylphenidate were not.
15 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
References • Bartók, E., Berecz, R., Glaub, T., & Degrell, I.
(2005). Cognitive functions in prepsychotic
patients. Progress in Neuro-
Psychopharmacology and Biological
Psychiatry, 29(4), 621-625.
• Chamberlain, S. R., Robbins, T. W., Winder-
Rhodes, S., Müller, U., Sahakian, B. J.,
Blackwell, A. D., & Barnett, J. H. (2011).
Translational approaches to frontostriatal
dysfunction in attention-deficit/hyperactivity
disorder using a computerized
neuropsychological battery. Biological
psychiatry, 69(12), 1192-1203.
• Chan, R. C. (2005). Sustained attention in
patients with mild traumatic brain
injury. Clinical Rehabilitation, 19(2), 188-
193.
• Clark L., Iversen S. D. & Goodwin G. M.
(2001) A neuropsychological investigation of
prefrontal cortex involvement in acute mania.
American Journal of Psychiatry. 158, 1605-
1611
• Clark, L., Iversen, S.D. & Goodwin, G.M.
(2002) Sustained attention deficit in bipolar
disorder. British Journal of Psychiatry. 180,
313 -31
• Clark L., Kempton M. J., Scarna A., Grasby P.
M. & Goodwin G. M. (2005) Sustained
attention-deficit confirmed in euthymic bipolar
disorder but not in first-degree relatives of
bipolar patients or euthymic unipolar
depression. Biological Psychiatry. 57, 183-187
• Coull J.T., Middleton H.C., Robbins T.W.,
Sahakian B.J. (1995) Clonidine and diazepam
have differential effects on tests of attention
and learning, Psychopharmacology, 120, 322-
332
• Elliott R., Sahakian B.J., Matthews K.,
Bannerjea A., Rimmer J., Robbins T.W.
(1997) Effects of methylphenidate on spatial
working memory and planning in healthy
young adults, Psychopharmacology, 131,
196-206
• Gau, S. F., & Huang, W. L. (2013). Rapid
visual information processing as a cognitive
endophenotype of attention deficit
hyperactivity disorder. Psychological
medicine, 44(02), 435-446.
• Jones, G.M.M., Sahakian, B.J., Levy, R.,
Warburton, D.M., & Gray, J.A. (1992). Effects
of acute subcutaneous nicotine on attention,
information processing and short-term
memory in Alzheimer's disease.
Psychopharmacology, 108(4), 485-494.
• Klekociuk, S. Z., & Summers, M. J. (2014a).
Exploring the validity of mild cognitive
impairment (MCI) subtypes: Multiple-domain
amnestic MCI is the only identifiable subtype
at longitudinal follow-up. Journal of clinical
and experimental neuropsychology, 36(3),
290-301.
• Klekociuk, S. Z., & Summers, M. J. (2014b).
Lowered performance in working memory and
attentional sub‐processes are most prominent
in multi‐domain amnestic mild cognitive
impairment subtypes. Psychogeriatrics,
14(1), 63-71.
• Klekociuk, S. Z., & Summers, M. J. (2014c).
The learning profile of persistent mild
cognitive impairment (MCI): a potential
diagnostic marker of persistent amnestic MCI.
European Journal of Neurology, 21(3), 470-
e24.
• Malojcic, B., Mubrin, Z., Coric, B., Susnic, M.,
& Spilich, G. J. (2008). Consequences of mild
traumatic brain injury on information
processing assessed with attention and short-
term memory tasks. Journal of
neurotrauma,25(1), 30-37.
• Parry, L., Shores, A., Rae, C., Kemp, A.,
Waugh, M. C., Chaseling, R., & Joy, P. (2004).
An investigation of neuronal integrity in
severe paediatric traumatic brain injury. Child
Neuropsychology, 10(4), 248-261.
• Prouteau, A., Verdoux, H., Briand, C., Lesage,
A., Lalonde, P., Nicole, L., Reinharz, D. & Stip,
E. (2004). The crucial role of sustained
attention in community functioning in
outpatients with schizophrenia. Psychiatry
research, 129(2), 171-177.
• Rock, P. L., Roiser, J. P., Riedel, W. J., &
Blackwell, A. D. (2013). Cognitive impairment
in depression: a systematic review and meta-
analysis. Psychological medicine, 1-12.
• Roiser, J. P., McLean, A., Ogilvie, A. D.,
Blackwell, A. D., Bamber, D. J., Goodyer, I.,
Jones, P. B. & Sahakian, B. J. (2005). The
subjective and cognitive effects of acute
phenylalanine and tyrosine depletion in
patients recovered from depression.
Neuropsychopharmacology, 30 (4), 775-785.
• Roque, D. T., Teixeira, R. A. A., Zachi, E. C.,
& Ventura, D. F. (2011). The use of the
16 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Cambridge Neuropsychological Test
Automated Battery (CANTAB) in
neuropsychological assessment: application in
Brazilian research with control children and
adults with neurological disorders. Psychology
& Neuroscience, 4 (2), 255-265.
• Sahakian, B., Jones, G., Levy, R., Gray, J., &
Warburton, D. (1989). The effects of nicotine
on attention, information processing, and
short-term memory in patients with dementia
of the Alzheimer type. The British Journal of
Psychiatry, 154(6), 797-800.
• Salmond, C. H., Chatfield, D. A., Menon, D. K.,
Pickard, J. D., & Sahakian, B. J. (2005).
Cognitive sequelae of head injury:
involvement of basal forebrain and associated
structures. Brain, 128(1), 189-200.
• Saunders, N. L., & Summers, M. J. (2011).
Longitudinal deficits to attention, executive,
and working memory in subtypes of mild
cognitive impairment. Neuropsychology,
25(2), 237.
• Saunders, N.J, & Summers M.J. (2010)
Attention and working memory deficits in mild
cognitive impairment. Journal of Clinical and
Experimental Neuropsychology 32(4), 350-
357.
• Sterr, A., Herron, K. A., Hayward, C., &
Montaldi, D. (2006). Are mild head injuries as
mild as we think? Neurobehavioral
concomitants of chronic post-concussion
syndrome. BMC neurology, 6(1), 7.
• Swainson, R., Hodges, J. R., Galton, C. J.,
Semple, J., Michael, A., Dunn, B. D., Liddon,
J. L., Robbins, T. W. & Sahakian, B. J. (2001).
Early detection and differential diagnosis of
Alzheimer’s disease and depression with
neuropsychological tasks. Dementia and
geriatric cognitive disorders, 12(4), 265-280.
• Turner D.C., Robbins T.W., Clark L., Aron
A.R., Dowson J.H., Sahakian B.J.,
(2003) Relative lack of cognitive effects of
methylphenidate in elderly male
volunteers, Psychopharmacology, 168, 455-
464
• Turner, D. C., Blackwell, A. D., Dowson, J. H.,
McLean, A., & Sahakian, B. J. (2005).
Neurocognitive effects of methylphenidate in
adult attention-deficit/hyperactivity
disorder. Psychopharmacology, 178(2-3),
286-295.
• Turner, D. C., Clark, L., Dowson, J., Robbins,
T. W., & Sahakian, B. J. (2004). Modafinil
improves cognition and response inhibition in
adult attention-deficit/hyperactivity
disorder. Biological psychiatry, 55(10), 1031-
1040.
17 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Episodic Memory
Episodic memory refers to the ability to store
and retrieve information about specific events or
“episodes”. The material stored about each
event is a unique combination of items which
occur at a specific time and place. An example
is seeing somebody in the street and
remembering that they are Mike and that you
previously met him on New Year’s Eve at your
sister’s house. This unique combination of item
(Mike), place (your sister’s house) and time (a
specific New Year’s Eve) comprise an episode.
This type of memory is distinct from information
remembered without such a context, for
example our general knowledge or vocabulary,
which is accrued throughout life without being
“tagged” with a specific time and unique
context. This latter form of memory is termed
semantic memory.
Episodic memory is the basis for much of our
personal autobiographical memory and is crucial
for everyday life. Without the ability to store
material from our present and retrieve
information from the past, we become unable to
function. The devastating effects of Alzheimer’s
disease are in large part due to the erosion of
this form of memory, as the disease
progressively removes the capacity to form new
memories. This leads to disorientation in time
and place, and eventually to loss of even long-
stored memories such as the identity of family
and friends.
The neural basis of episodic memory has been
studied since the famous case in the 1950s of
Henry Molaison, or HM, a patient who underwent
surgical resection of the medial temporal lobes
and was rendered profoundly amnesic, unable to
store new information beyond a few minutes,
despite being still able to acquire new motor
skills and having otherwise intact language,
perceptual and cognitive skills. Since then, there
has been a large amount of research in animals
and patient populations, including imaging
studies, confirming the key role that medial
temporal lobe structures, particularly the
hippocampus, play in the formation and retrieval
of information. It is self-evident that these
processes of episodic memory do not occur in
isolation, but work in concert with and depend
on input from perceptual areas and strategic
coordination of resources from frontal regions
involved in executive control.
Decline in episodic memory is an unfortunate
characteristic of ageing. However, progressive
and severe loss of episodic memory is not
normal, and is considered a key feature of
Alzheimer’s disease. This is due to the fact that
Alzheimer’s pathology is first present in the
hippocampus and medial temporal lobe areas,
before inexorably progressing throughout the
brain to finally affect all areas of the cortex (see
Figure 4), at which point multiple, profound
deficits are seen in a wide range of cognitive
domains.
Figure 4: Smith et al., (2002) Progression of
Alzheimer's disease pathology. The earliest
pathological changes are present in the medial
temporal lobe, spreading at a later stage to other brain
areas, particularly those connected with the MTL,
resulting in more widespread cognitive changes.
Key references • Squire, L. R., & Zola, S. M. (1998). Episodic
memory, semantic memory, and amnesia.
Hippocampus, 8(3), 205-211.
• Tulving, E. (1985). Elements of episodic
memory.
• Tulving, E. (2002). Episodic memory: from
mind to brain. Annual review of psychology,
53(1), 1-25.
• Smith, A. D. (2002). Imaging the progression
of Alzheimer pathology through the
brain. roceedings of the National Academy of
Sciences, 99(7), 4135-4137.
Paired Associates Learning (PAL)
18 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
As described above, one of the hallmarks of
episodic memory is the binding of separate
pieces of information together, such as a person
and a specific time or place. This makes tests
which capture this feature particularly useful as
tests of episodic memory. PAL achieves this by
explicitly requiring the recall of a location which
was previously paired with an object.
Description of the test
The task consists of a number of stages that the
subject must complete in order. For each stage,
boxes are displayed on the screen. These boxes
open one at a time in a randomised order. One
or more of them will contain a pattern. The
patterns shown in the boxes are then displayed
one at a time in the middle of the screen, and
the subject must touch the box where the
pattern was originally located.
If the subject makes an error on a stage, the
patterns are re-presented to remind the
participant of their locations. For each stage, the
same patterns may be re-presented up to a set
number of times. When the participant gets all
the locations correct, they proceed to the next
stage. If they cannot complete a stage correctly,
the test terminates. At the easiest stages of PAL,
there is a single pattern to remember the
location of, and at the most difficult there are
eight patterns.
The patterns are designed to be difficult to
verbalise so that verbal rehearsal cannot be
used as a strategy. Their nonverbal nature also
allows the test to be used in international studies
without the need for stimuli translation.
Participants are allowed multiple attempts at
each trial, with automatic re-presentation of all
stimuli after each attempt until the stage is
passed or terminated. The test is adaptive so
that if a trial is not completed despite multiple
attempts, the test automatically terminates and
the error score calculated includes an
adjustment for errors at those stages that were
not attempted.
Administration time is approximately 8 minutes,
but depends on the performance of the
participant.
Core outcomes
Total errors (adjusted)
Definition: The number of times the subject
chose the incorrect box for a stimulus on
assessment problems but with an adjustment
for the estimated number of errors they would
have made on any problems, attempts & recalls
they did not reach due to failing or aborting the
test.
CANTAB Paired Associates Learning test
19 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Cognitive domains assessed
Paired associates learning is designed to assess
visual episodic memory and learning. Tests of
convergent validity have shown that there is a
modest correlation between the PAL and story
recall (-.19 immediate; -.21 delayed recall.
Smith et al., 2013). However, the verbal
component to story recall does limit the
comparability of these tasks. In terms of the
ecological validity of the measures, there is
strong correspondence between PAL and self-
reported memory problems (Swainson et al.,
2001), as well as other measures of memory.
Brain systems
Successful performance of the PAL test is
dependent on functional integrity of the
temporal lobe, particularly the entorhinal cortex,
but is also affected by resections of the frontal
lobe (Owen, Sahakian, Semple, Polkey, &
Robbins, 1995). Impairment on the CANTAB PAL
test correlates with hippocampal volume loss in
schizophrenia (Keri et al., 2012).
The PAL paradigm has been modified for use in
the MRI scanner, allowing direct assessment of
the brain areas involved in performance. This
has consistently shown involvement of the
medial temporal lobe, particularly the
hippocampus and parahippocamal regions (de
Rover et al., 2011; Owen et al., 1995; Figure 5).
De Rover et al. (2011) further showed that there
were differences in the pattern of hippocampal
activation during the PAL in MCI patients
compared to normal controls.
These data support the use of this measure as a
sensitive marker of hippocampal function.
Pharmacological data
The PAL task was designed to be a close
analogue to tasks used in both primate and
rodent research (e.g. Bussey et al., 2012). In
these models, performance has been found to
be dependent on the function of the
hippocampus which is fundamental to learning
associations between objects and locations.
The PAL task has been used in a range of
pharmacological studies, particularly those
targeting cholinergic systems implicated in
Alzheimer’s disease (e.g. scopolamine) in both
animals (e.g. Taffe et al, 2002) and humans. A
summary of the data from published
pharmacological studies in healthy participants
is presented below. These extensive data
demonstrate the sensitivity of these measures
to both pharmacological impairment and
improvement in performance. Of particular
interest is the presence of dose dependent
effects of scopolamine in healthy controls.
Ageing
Consistent with the early development of the
medial temporal lobes, episodic memory
improves rapidly in early childhood and remains
relatively stable through mid-life, before
worsening in later life (Figure 6).
Gender and education have also been found to
impact on error scores, such that women and
those with higher educational attainment
perform better on the task. However, there are
no significant interactions between age,
education and gender.
A
B
Figure 5: Significant bilateral hippocampal and
parahippocamal activation during the encoding (A) and
retrieval (B) of PAL in elderly subjects. Rover et al. (2011)
20 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Sensitivity to impairment in clinical populations
AD and MCI
Alzheimer’s disease
The medial temporal lobes are susceptible to
Alzheimer’s pathology, particularly early in the
course of the disease (Smith et al., 2002) and
problems with episodic memory can be the first
warning signs of AD. The sensitivity of PAL to
hippocampal function has led to the suggestion
that it may be used for the early and differential
diagnosis of AD (Blackwell et al., 2004; de Jager,
Lesk, Zhi, Marsico, & Chandler, 2008). Across
studies the sensitivity and specificity indices
were 0.94 and 0.91 respectively for detecting
AD compared to elderly non-demented controls.
The predictive ability for detecting incipient AD
in populations with mild cognitive impairment is
discussed below.
As would be expected, the rate of decline in PAL
performance in AD is greater than that seen on
average in MCI or healthy elderly populations
(Figure 7). For example, PAL total error score
(adjusted) increased by an average of 24 errors
over one year in patients with dementia of the
Alzheimer’s type (Fowler et al., 2002).
Mild cognitive impairment
Differentiating MCI from normal ageing is
challenging, since MCI represent a
heterogeneous group, with only certain
individuals progressing to Alzheimer's or
another underlying cognitive disease.
Nonetheless, PAL scores have a sensitivity of
0.83 and a specificity of 0.82 in differentiating
adults with MCI from healthy older adults
(Chandler et al., 2008). In a study at the
University of Tasmania, patients with amnestic
MCI showed poorer performance on PAL than
either controls or non-amnestic MCI patients at
baseline. When reassessed 10 months later,
patients with amnestic MCI had worsened by an
average of four errors at the six-pattern stage.
In contrast, PAL scores of patients with non-
amnestic MCI, who are at lower risk for
Alzheimer's disease, changed by less than one
error (Saunders & Summers, 2011).
An important issue in the study of MCI is
predicting which participants will go on to
develop AD and which will not. A meta-analysis
of 19 longitudinal studies has reported that
approximately 10% of MCI cases per year
progress to develop dementia (Bruscoli &
Lovestone, 2004). PAL has shown considerable
promise in this regard. Swainson et al. (2001)
examined the ability of PAL to distinguish AD
from controls and those with questionable
dementia (QD) over 24 months. At baseline,
both AD and QD participants were impaired on
PAL, and there was a significant correlation
between MMSE and PAL. PAL six-pattern error
score was able to classify group membership
with 98% accuracy. At baseline, those with QD
appeared to be split into two distinct groups:
one whose PAL scores resembled those with AD
and one that resembled control subjects. These
patients were followed up 6-12 months later, by
which time the QD subjects had split into two
groups: those whose performance had declined
similarly to AD, and those whose performance
had remained stable. By 24 months, all patients
with poor and deteriorating performance had
received a diagnosis of AD.
Figure 6: Age profile of PAL errors showing an increase in
errors with age in healthy participants
21 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Similar findings have been reported in a series
of studies by Fowler et al. (1995, 1997, 2002).
They demonstrate that PAL is able to predict
which participants with memory problems will go
on to have AD two years later. The authors
found that while participants with poor
performance and declining trajectories went on
to have a diagnosis of probable AD, those with
higher baseline scores and stable performance
did not (Fowler et al., 2002. See Figure 7). Using
PAL alongside a test of naming, patients with
relatively high baseline scores remained
dementia-free at 32 months, while all of those
impaired on both tests at baseline went on to
receive a diagnosis of probable AD (Blackwell et
al., 2004). Using the PAL alongside the
Addenbrooke’s Cognitive Evaluation (ACE),
Mitchell et al. (2009) obtained a sensitivity to
conversion to AD of 94%. This compared to
other cognitive tests, such as measures of
semantic memory and executive function, which
showed very low sensitivity to conversion,
ranging from 0-25%. These and similar findings
have led to the suggestion that PAL may be a
useful marker for the subsequent conversion of
MCI to AD (Blackwell et al., 2004; Sahakian et
al., 1988).
Recent studies examining the profile of
impairment in different subtypes of MCI have
found that participants with amnestic MCI (a-
MCI) show poorer performance than those with
non-amnestic MCI on PAL (Klekociuk &
Summers 2014a; Saunders & Summers 2011).
Together with other measures (including indices
from RVP, SWM and MTS), PAL scores
contributed significantly to the discrimination of
MCI cases from controls (Klekociuk & Summers,
2014c).
Non-Alzheimer’s dementia
Less common subtypes of dementia (and other
rarer neurodegenerative conditions) are
associated with a range of cognitive, behavioural
and functional deficits, and there are a number
of different clinical diagnostic criteria, of which
memory is a part. While memory assessment
can be helpful in earlier stages of assessment in
these diagnoses, it may not be a presenting
symptom until later stages of other disease
progression.
For Lewy Body Dementia (LBD), there is a study
showing that patients performed poorly on the
PAL task. Interestingly, in this study their
performance was more severely impaired than
patients with AD, which suggests that PAL may
have sensitivity to memory symptoms
associated with LBD (Galloway et al., 1992).
Fronto-temporal dementia (FTD) is often a
complex presentation and memory loss is not
typically a key feature in the early stages.
Nevertheless, from the few studies conducted,
there is some evidence that PAL performance is
impaired in the early stages of FTD presentation
(e.g. Deakin et al., 2003; Lee et al., 2003).
Figure 7: Paired associates learning decline over 24 months in individuals with questionable
dementia (Fowler, Saling, Conway, Semple, & Louis, 2002).
22 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Psychiatric and mood disorders
Depression
There is some debate regarding the sensitivity
of PAL to depression. Swainson et al. (2001)
showed that older adults with major unipolar
depression had PAL scores similar to age-
matched healthy controls, with little overlap
between these groups and patients with mild
Alzheimer’s disease. Similarly, Sweeney et al.
(2000) did not find a significant difference in PAL
performance between their young unipolar
depressed patients and healthy controls, but did
find that mixed/manic patients made more
errors than healthy subjects. O’Brien et al.
(1993) found that seasonal affective disorder
(SAD) patients were significantly impaired in
terms of number of trials to reach criterion on
PAL, compared both to healthy controls and to
their own performance once recovered.
A recent meta-analysis of studies using CANTAB
tests in depressed patients (Rock et al., 2013)
brought together these and similar studies and
revealed that, while PAL performance was
reduced in medicated currently depressed
patients, no significant change was seen in a
smaller number of studies of those not currently
medicated.
Schizophrenia
Patients with Schizophrenia show a level of
impairment similar to that seen in AD
(Gabrovska-Johnson et al., 2003). In addition,
there was a significant correlation between right
hemisphere ventricle size and performance on
the PAL in patients with Schizophrenia. Bartók
et al. (2005) compared the performance of the
patients to that of the CANTAB standardization
database. The performance of the prepsychotic
patients was significantly lower compared to the
healthy individuals on the PAL test (p<0.001),
as well as in tests of frontal lobe function.
Neurological and movement disorders
Multiple sclerosis
MS patients performed significantly worse than
controls on PAL. In addition, in MS patients
performance was associated with levels of
disease-specific markers (glutamate) in
hippocampus, thalamus and cingulate (Muhlert
et al., 2014). This again demonstrates the
sensitivity of the test to pathology of the
hippocampus.
Traumatic brain injury
TBI patients make more errors than controls on
the PAL test (Salmond, Chatfield, Menon,
Pickard, & Sahakian, 2005), and the degree of
impairment is associated with increased atrophy
in the hippocampal formation; this is measured
by white matter density (Salmond, Menon, et
al., 2006), again implicating this structure as a
key area mediating successful performance. A
later study examining changes in brain structure
outside the hippocampus found a statistically
significant negative correlation between
measures of white matter integrity in the corpus
callosum on diffusion weighted imaging and
memory performance (r = -0.588, P = .005)
(Holli et al., 2010).
References • Bartók, E., Berecz, R., Glaub, T., & Degrell, I.
(2005). Cognitive functions in prepsychotic
patients. Progress in Neuro-
Psychopharmacology and Biological
Psychiatry, 29, 621-625.
• Blackwell, A. D., Sahakian, B. J., Vesey, R.,
Semple, J. M., Robbins, T. W., & Hodges, J. R.
(2004). Detecting dementia: novel
neuropsychological markers of preclinical
Alzheimer's disease. Dementia and Geriatric
Cognitive Disorders, 17, 1-2.
• Bruscoli, M., & Lovestone, S. (2004). Is MCI
really just early dementia? A systematic
review of conversion studies. International
Psychogeriatrics, 16, 129-140.
• Bussey, T. J., Holmes, A., Lyon, L., Mar, A. C.,
McAllister, K. A. L., Nithianantharajah, J., ... &
23 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Saksida, L. M. (2012). New translational
assays for preclinical modelling of cognition in
schizophrenia: the touchscreen testing
method for mice and rats.
Neuropharmacology, 62(3), 1191-1203.
• Chandler, J. M., Marsico, M., Harper-Mozley,
L., Vogt, R., Peng, Y., Lesk, V., & de Jager, C.
(2008). P3-111: Cognitive assessment:
Discrimination of impairment and detection of
decline in Alzheimer's disease and mild
cognitive impairment. Alzheimer's &
Dementia, 4(4), T551-T552.
• de Jager, C. A., Lesk, V. E., Zhu, X., Marsico,
M., & Chandler, J. (2008). P3-120: Episodic
memory test constructs affect discrimination
between healthy elderly and cases with mild
cognitive impairment and Alzheimer's disease.
Alzheimer's & Dementia, 4(4), T554-T555.
• de Rover, M., Pironti, V. A., McCabe, J. A.,
Acosta-Cabronero, J., Arana, F. S., Morein-
Zamir, S., Hodges, J. R., Robbins, T. W.,
Fletcher, P. C., Nestor, P. J. & Sahakian, B. J.
(2011). Hippocampal dysfunction in patients
with mild cognitive impairment: a functional
neuroimaging study of a visuospatial paired
associates learning task.
Neuropsychologia, 49(7), 2060-2070.
• Deakin J.B., Aitken M.R., Dowson J.H.,
Robbins T.W., Sahakian B.J.,
(2003) Diazepam produces disinhibitory
cognitive effects in male
volunteers, Psychopharmacology, 173(1-2),
88-97
• Fowler KS, Saling MM, Conway EL, Semple JM,
Louis WJ (1995): Computerized delayed
matching to sample and paired associate
performance in the early detection of
dementia. Applied Neuropsychology 2: 72–78
• Fowler KS, Saling MM, Conway EL, Semple JM,
Louis WJ. (2002) Paired associate
performance in the early detection of DAT. J
Int Neuropsychol Soc. 8:58-71.
• Fowler, K. S., Saling, M. M., Conway, E. L.,
Semple, J. M., & Louis, W. J. (1997).
Computerized neuropsychological tests in the
early detection of dementia: prospective
findings. Journal of the International
Neuropsychological Society, 3(02), 139-146.
• Gabrovska-Johnson, V. S., Scott, M., Jeffries,
S., Thacker, N., Baldwin, R. C., Burns, A.,
Lewis, S. W. & Deakin, J. F. W. (2003). Right-
hemisphere encephalopathy in elderly
subjects with schizophrenia: evidence from
neuropsychological and brain imaging
studies. Psychopharmacology, 169, 367-375.
• Galloway, P. H., Shagal, A., Cook, J. H.,
Ferrier, I. N., & Edwardson, J. A. (1992).
Visual pattern recognition memory and
learning deficits in senile dementias of
Alzheimer and Lewy body types. Dementia
and Geriatric Cognitive Disorders, 3(2), 101-
107.
• Holli, K. K., Wäljas, M., Harrison, L.,
Liimatainen, S., Luukkaala, T., Ryymin, P.,
Eskola, E., Soimakallio, S., Öhman, J. &
Dastidar, P. (2010). Mild traumatic brain
injury: tissue texture analysis correlated to
neuropsychological and DTI findings.
Academic radiology, 17(9), 1096-1102.
• Kéri, S., Szamosi, A., Benedek, G., &
Kelemen, O. (2012). How does the
hippocampal formation mediate memory for
stimuli processed by the magnocellular and
parvocellular visual pathways? Evidence from
the comparison of schizophrenia and amnestic
mild cognitive impairment
(aMCI).Neuropsychologia, 50, 3193-3199
• Klekociuk, S. Z., & Summers, M. J. (2014a).
Exploring the validity of mild cognitive
impairment (MCI) subtypes: Multiple-domain
amnestic MCI is the only identifiable subtype
at longitudinal follow-up. Journal of clinical
and experimental neuropsychology, 36, 290-
301.
• Klekociuk, S. Z., & Summers, M. J. (2014c).
The learning profile of persistent mild
cognitive impairment (MCI): a potential
diagnostic marker of persistent amnestic MCI.
European Journal of Neurology, 21, 470-e24.
• Lee, A. C., Rahman, S., Hodges, J. R.,
Sahakian, B. J., & Graham, K. S. (2003).
Associative and recognition memory for novel
objects in dementia: implications for
diagnosis. European Journal of
Neuroscience, 18(6), 1660-1670.
• Mitchell, J., Arnold, R., Dawson, K., Nestor, P.
J., & Hodges, J. R. (2009). Outcome in
subgroups of mild cognitive impairment (MCI)
is highly predictable using a simple
algorithm. Journal of neurology, 256(9),
1500-1509.
• Muhlert, N., Atzori, M., De Vita, E., Thomas,
D. L., Samson, R. S., Wheeler-Kingshott, C.
A., ... & Ciccarelli, O. (2014). Memory in
24 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
multiple sclerosis is linked to glutamate
concentration in grey matter regions. Journal
of Neurology, Neurosurgery & Psychiatry,
jnnp-2013.
• Muller U., Clark L., Lam M.L., Moore R.M.,
Murphy C.L., Richmond N.K., Sandhu R.S.,
Wilkins I.A., Menon D.K., Sahakian B.J.,
Robbins T.W., (2005) Lack of effects of
guanfacine on executive and memory
functions in healthy male volunteers.
Psychopharmacology, 182, 205-213
• O'Brien, J. T., Sahakian, B. J., & Checkley, S.
A. (1993). Cognitive impairments in patients
with seasonal affective disorder. The British
Journal of Psychiatry, 163(3), 338-343.
• Owen, A. M., Sahakian, B. J., Semple, J.,
Polkey, C. E. and Robbins, T. W. (1995) Visuo-
spatial short-term recognition memory and
learning after temporal lobe excision, frontal
lobe excision or amygdalo-hippocampectomy
in man. Neuropsychologia, 33, 1-24.
• Rock, P. L., Roiser, J. P., Riedel, W. J., &
Blackwell, A. D. (2013). Cognitive impairment
in depression: a systematic review and meta-
analysis. Psychological medicine, 1-12.
• Sahakian, B. J., Morris, R. G., Evenden, J. L.,
Heald, A., Levy, R., Philpot, M., & Robbins, T.
W. (1988). A comparative study of
visuospatial memory and learning in
Alzheimer-type dementia and Parkinson's
disease. Brain, 111(3), 695-718.
• Salmond, C. H., Chatfield, D. A., Menon, D. K.,
Pickard, J. D., & Sahakian, B. J. (2005).
Cognitive sequelae of head injury:
involvement of basal forebrain and associated
structures. Brain, 128(1), 189-200.
• Salmond, C. H., Menon, D. K., Chatfield, D. A.,
Williams, G. B., Pena, A., Sahakian, B. J., &
Pickard, J. D. (2006). Diffusion tensor imaging
in chronic head injury survivors: correlations
with learning and memory indices.
Neuroimage, 29(1), 117-124.
• Saunders, N. L., & Summers, M. J. (2011).
Longitudinal deficits to attention, executive,
and working memory in subtypes of mild
cognitive impairment. Neuropsychology,
25(2), 237.
• Smith, A. D. (2002). Imaging the progression
of Alzheimer pathology through the
brain. Proceedings of the National Academy of
Sciences, 99(7), 4135-4137
• Smith, P. J., Need, A. C., Cirulli, E. T., Chiba-
Falek, O., & Attix, D. K. (2013). A comparison
of the Cambridge Automated
Neuropsychological Test Battery ( CANTAB)
with “traditional” neuropsychological testing
instruments, Journal of clinical and
experimental neuropsychology, 35(3), 319-
328.
• Swainson, R., Hodges, J. R., Galton, C. J.,
Semple, J., Michael, A., Dunn, B. D., ... &
Sahakian, B. J. (2001). Early detection and
differential diagnosis of Alzheimer’s disease
and depression with neuropsychological tasks.
Dementia and geriatric cognitive disorders,
12(4), 265-280.
• Sweeney, J. A., Kmiec, J. A., & Kupfer, D. J.
(2000). Neuropsychologic impairments in
bipolar and unipolar mood disorders on the
CANTAB neurocognitive battery. Biological
psychiatry, 48(7), 674-684.
• Taffe, M. A., Weed, M. R., Gutierrez, T., Davis,
S. A., & Gold, L. H. (2002). Differential
muscarinic and NMDA contributions to visuo-
spatial paired-associate learning in rhesus
monkeys. Psychopharmacology, 160(3), 253-
262.
25 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Delayed match to sample (DMS)
Delayed matching to sample is based on
paradigms developed for use in memory
research with non-human primates. These were
designed to tap memory processes in a non-
verbal manner and control for any deficits in
perception or attention which may be
responsible for decreases in performance. This
is achieved by having a simultaneous condition
where the participant matches simultaneously
presented stimuli to an identical item and an
array of visually similar items. Increasing the
delay between offset of the item to be
remembered and the onset of the choices makes
this task demanding of memory capacity, and
therefore sensitive to deficits of the medial
temporal lobe.
Description of the test
DMS is a test of simultaneous and delayed
matching to sample. This test assesses visual
matching ability and visual recognition memory.
Participants have to select from four similar
complex visual patters displayed at the bottom
of the screen the one that is the same as a
pattern displayed in the centre of the screen. In
some trials, the choice patterns at the bottom of
the screen and the sample pattern in the middle
of the screen are displayed simultaneously
whereas in others the choice patterns are only
shown after the sample pattern (delays of 0, 4
or 12 seconds between the presentation of the
sample pattern and the choice patterns).
Administration time: approximately 7 minutes
Core outcomes
Key Outcome
Measures
Definition
Percent correct The percentage of assessment trials
during which the subject selected the
correct box on their first box choice
Median Correct
latency
The median latency
from the available choices being displayed to the subject choosing the correct choice on assessment trials where the subject’s
first choice is correct
Probability of error given error
This measure reports the probability of an error occurring when the previous trial was responded to
incorrectly and is
used in calculations of A’ and B’’ (Note that this is incalculable if <1
errors made)
CANTAB Delayed Match to Sample test
26 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Cognitive domains assessed
A study looking at the convergent validity of the
CANTAB tests in a clinical sample confirmed that
there was a significant association between
delayed matching to sample and a pencil-and–
paper measure of the ability to remember and
match visual patterns (Torgersen et al., 2012).
This measure was not correlated with indices of
verbal memory or executive function.
Brain Systems
Many lesion studies in both humans and non-
human primates have indicated that delayed
matching to sample is primarily sensitive to
damage in the medial temporal lobes
(particularly hippocampus) and frontal lobes
(Sahgal and Iversen, 1978).
Imaging work has confirmed the contribution of
the medial temporal lobes and furthermore has
demonstrated that this contribution is delay-
dependent. Performance at longer delays is
more dependent on the medial temporal lobes.
At short delays, the task can be performed on
the basis of perceptual features, and therefore
is more dependent on visual processing areas,
such as the occipital lobes (Elliot and Dolan,
1999).
These findings have been more recently
confirmed in a study by Picchioni et al., (2007)
which supports the greater involvement of
medial temporal and frontal structures with
increasing delay periods (Figure 8).
Pharmacological manipulations
Matching to sample performance shows
established sensitivity to pharmacological
manipulations. Dose-dependent reductions in
performance were seen following administration
of scopolamine. Reductions in performance were
also seen following administration of the
adrenergic agonist clonidine. Conversely, small
but non-significant increases were seen
following administration of the
acetylcholinesterase inhibitor donepezil.
Administration of modafinil also produced a
modest increase in performance.
Figure 8: Picchioni et al., (2007). Increasing activation
in the anterior cingulate (upper panel) and in the
medial temporal lobe (lower panel) with increasing
maintenance delay across conditions (12,000 ms >
4,000 ms > simultaneous). Results are superimposed
onto a standard template brain.
Ageing
The effects of ageing on DMS are illustrated in
Figure 9 using published data in a large Chinese
sample. These data show a gradual decline with
age in performance on this task.
Figure 9: Age effects on DMS from Lee et al., (2013).
N=184
14
15
16
17
18
19
20s 30s 40s 50s >60
DM
S s
co
re
Age Category
27 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Sensitivity to impairment in clinical populations
AD and MCI
Alzheimer’s disease
As can be expected on the basis of the clear role
the medial temporal lobes play in AD,
performance on this memory task is affected
early in the course of AD and correlates with Mini
Mental State Examination (MMSE) performance
(Swainson et al., 2001). The memory profile of
AD patients shows a delay-dependent deficit. As
the delay period increased, and correspondingly
the medial temporal lobe demands increased,
performance of the AD patients became
increasingly poor (Abas et al., 1990).
Importantly, researchers have found that DMS
can aid in differentiating AD from MCI (Saunders
& Summers 2010) and depression in older adults
(Abas et al., 1990). Interestingly, in the study
group, although both groups were impaired in
the delayed MTS condition, AD patients made
more random distractor errors, and the
depressed patients’ degree of response slowing
was not related to task difficulty, unlike the
control group and the AD group, where reaction
times increased with task difficulty.
Mild cognitive impairment
Consistent with the memory impairments
characteristic of MCI, impairments in MTS
performance have been found in these patients
compared to controls (Klekociuk & Summers
2014 c), although of less severity than those
seen in AD (Swainson et al., 2001; Saunders &
Summers 2010).
There are some differences in performance in
different MCI subtypes, with non-amnestic MCI
showing relatively intact performance
(Klekociuk & Summers 2014 b).
Psychiatric and mood disorders
Depression
Depressed participants often report subjective
cognitive impairment, and differentiating
dementia and depression in older adults can be
challenging.
A recent meta-analysis showed that impairment
was observed in both unmedicated and
medicated patients who were currently
depressed (Rock et al., 2013). However, these
deficits were found to resolve after remission of
the depression.
Middle-aged adults with severe depression show
impairments both in accuracy and latency on
DMS (Elliott et al., 1996). Critically, DMS scores
show a moderate but significant correlation (r =
0.5) with clinical measures of depression such
as the Montgomery-Asberg Depression Rating
Scale and the Clinical Interview for Depression
(Elliott et al., 1996).
Depressed individuals with bipolar I disorder
show normal performance in the simultaneous
condition that assesses perceptual ability
without memory demand, but show increasing
impairment as the delay period increases
(Rubinsztein et al., 2006). This effect has also
been shown in bipolar patients during euthymic
states (Rubinsztein et al., 2000).
An interesting feature of depressed individuals’
performance on this task is the significantly
increased likelihood of making an error after an
error, i.e. increased sensitivity to negative
feedback. This effect is seen to a significantly
greater extent in depressed individuals than in
patients with other neurocognitive disorders,
such as Parkinson’s disease and Schizophrenia,
or neurosurgical patients (Figure 10: Elliot et
al., 1996). This over-sensitivity to negative
feedback is an example of a negative bias in
information processing that is seen in
depression.
28 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
With regards to the differentiation of AD and
depression in older adults, Abas et al. (1990)
found that elderly depressed patients were not
impaired on simultaneous matching to sample
but were as impaired as AD patients in accuracy
and reaction time on the DMS task. Both the
depressed and the AD patients also showed a
delay-dependent deficit in memory. Their
performance was different from that of AD
patients in two respects, however. Firstly, the
AD patients made significantly more random
distractor errors than the depressed patients or
the controls, with significantly fewer shape
distractor errors than colour distractor errors
(unlike the other groups, who made roughly
equal numbers of each error type). Secondly,
the depressed patients’ degree of response
slowing was not related to task difficulty,
whereas in the control group and the AD group,
reaction times increased with task difficulty.
Neurological and movement disorders
Traumatic brain injury
Consistent with the impact that TBI can have on
cognitive and attentional systems, Salmond et
al. (2005) showed that TBI patients make
significantly more errors and responded more
slowly relative to healthy controls. However,
Parry et al. (2004) found that scores were within
normal limits. The differences between the two
studies are probably accounted for by
differences in the severity of impairment in this
heterogeneous condition.
ADHD
There have been fewer studies examining
performance in ADHD on this task. However,
Gau and Huang (2014) found that, compared
with controls, participants with ADHD performed
worse in medial temporal lobe (MTS) tasks after
controlling for sex, age, co-morbidity, parental
educational levels and IQ. This may be
secondary to the attentional problems evident in
ADHD.
0.0
0.1
0.2
0.3
0.4
Depressedpatients N=28
Parkinson'sdisease N=17
Schizophreniapatients N=11
Neurosurgicalpatients N=23
Healthycontrols N=22
Pro
bab
ility
of
erro
r af
ter
erro
r
Figure 10: probability of an error given an error in different patient groups. Journal of Neurology:
‘Abnormal response to negative feedback in unipolar depression: evidence for a diagnosis specific
impairment’ Elliott, Sahakian, Herrod, Robbins, Paykel (1996)
29 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
References • Abas, M. A., Sahakian, B. J., & Levy, R.
(1990). Neuropsychological deficits and CT
scan changes in elderly
depressives. Psychological medicine, 20(03),
507-520.
• Elliott, R., & Dolan, R. J. (1999). Differential
neural responses during performance of
matching and nonmatching to sample tasks at
two delay intervals. The Journal of
Neuroscience, 19(12), 5066-5073.
• Elliott, R., Sahakian, B. J., McKay, A. P.,
Herrod, J. J., Robbins, T. W., & Paykel, E. S.
(1996). Neuropsychological impairments in
unipolar depression: the influence of
perceived failure on subsequent
performance. Psychological medicine, 26(05),
975-989.
• Gau, S. F., & Huang, W. L. (2014). Rapid
visual information processing as a cognitive
endophenotype of attention deficit
hyperactivity disorder. Psychological
medicine, 44(02), 435-446.
• Klekociuk, S. Z., & Summers, M. J. (2014b).
Lowered performance in working memory and
attentional sub‐processes are most prominent
in multi‐domain amnestic mild cognitive
impairment subtypes. Psychogeriatrics,
14(1), 63-71.
• Klekociuk, S. Z., & Summers, M. J. (2014c).
The learning profile of persistent mild
cognitive impairment (MCI): a potential
diagnostic marker of persistent amnestic MCI.
European Journal of Neurology, 21(3), 470-
e24.
• Lee, A., Archer, J., Wong, C. K. Y., Chen, S.
H. A., & Qiu, A. (2013). Age-Related Decline
in Associative Learning in Healthy Chinese
Adults. PloS one, 8(11), e80648.
• Parry, L., Shores, A., Rae, C., Kemp, A.,
Waugh, M. C., Chaseling, R., & Joy, P. (2004).
An investigation of neuronal integrity in
severe paediatric traumatic brain injury. Child
Neuropsychology, 10(4), 248-261.
• Picchioni, M., Matthiasson, P., Broome, M.,
Giampietro, V., Brammer, M., Mathes, B.,
Fletcher, P., Williams, S. & McGuire, P.
(2007). Medial temporal lobe activity at
recognition increases with the duration of
mnemonic delay during an object working
memory task. Human brain mapping, 28(11),
1235-1250.
• Rock, P. L., Roiser, J. P., Riedel, W. J., &
Blackwell, A. D. (2013). Cognitive impairment
in depression: a systematic review and meta-
analysis. Psychological medicine, 1-12.
• Rubinsztein, J. S., Michael, A., Paykel, E. S.,
& Sahakian, B. J. (2000). Cognitive
impairment in remission in bipolar affective
disorder. Psychological medicine, 30(05),
1025-1036.
• Rubinsztein, J. S., Michael, A., Underwood, B.
R., Tempest, M., & Sahakian, B. J. (2006).
Impaired cognition and decision-making in
bipolar depression but no ‘affective bias’
evident. Psychological Medicine, 36(05), 629-
639.
• Sahgal, A., & Iversen, S. D. (1978). The
effects of foveal prestriate and inferotemporal
lesions on matching to sample behaviour in
monkeys. Neuropsychologia, 16(4), 391-406.
• Salmond, C.H., Chatfield, D.A., Menon, D.K.,
Pickard, J.D., & Sahakian, B.J. (2005).
Cognitive sequelae of head injury:
involvement of basal forebrain and associated
structures. Brain, 128(1), 189-200.
• Saunders, N.J, & Summers M.J. (2010)
Attention and working memory deficits in mild
cognitive impairment. Journal of Clinical and
Experimental Neuropsychology 32(4), 350-
357.
• Swainson, R., Hodges, J. R., Galton, C. J.,
Semple, J., Michael, A., Dunn, B. D., Iddon, J.
L., Robbins, T. W. & Sahakian, B. J. (2001).
Early detection and differential diagnosis of
Alzheimer’s disease and depression with
neuropsychological tasks. Dementia and
geriatric cognitive disorders, 12(4), 265-280.
• Torgersen, J., Flaatten, H., Engelsen, B. A., &
Gramstad, A. (2012). Clinical validation of
Cambridge neuropsychological test
automated battery in a Norwegian epilepsy
population. Journal of Behavioral and Brain
Science, 2, 108.
30 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Working memory and executive function
Working memory can be defined as the ability to
hold material in mind while that material is
actively processed. This cognitive component is
critical to many everyday activities such as
mental arithmetic and following multi-step
instructions and directions. A network of brain
areas is involved in these kinds of tasks,
consisting of parietal, temporal and prefrontal
cortex. As a key cognitive skill dependent on a
network of areas, it is impaired in a range of
developmental and degenerative disorders,
particularly those impacting on the prefrontal
cortex and dopaminergic neurotransmission,
such as schizophrenia and ADHD.
Executive function is perhaps the most complex
and multifaceted cognitive domain. It is
comprised of multiple sub-processes, only some
of which will be addressed here. Broadly,
executive function allocates attentional
resources and coordinates the work of other
cognitive systems to guide action to fulfil goals.
An example of this can be seen in shopping for
food at the supermarket: the shopper has to
formulate a goal, which is to buy what they
need, employ their (episodic) memory of where
things are to navigate through the supermarket,
find what they need on crowded shelves of
similar items (selective attention), keep track of
what they have bought so far (working
memory). They have to do all this while resisting
the urge to buy items which would blow the
budget, and behave in socially appropriately
ways to their fellow shoppers and staff. At the
end of all this, they have to find where they
parked their car (episodic memory again).
The coordination of these individually complex
tasks, planning, strategic thinking and inhibitory
control are all key aspects of executive function.
These components depend on the frontal lobes,
with different sub-divisions playing a role in
distinct aspects. Damage to the frontal lobes,
following head injury, for example, is associated
with impairments of executive function, which
can have a devastating effect on the ability of
individuals to perform in cognitively demanding
or unstructured real-life situations, and to make
decisions. Deficits are also seen in conditions
such as schizophrenia which also affect the pre-
frontal cortex.
Key references • Baddeley, Alan D., and Graham Hitch.
"Working memory." Psychology of learning
and motivation 8 (1974): 47-89.
• D'Esposito, M., Detre, J. A., Alsop, D. C.,
Shin, R. K., Atlas, S., & Grossman, M.
(1995). The neural basis of the central
executive system of working memory.
Nature, 378(6554), 279-281.
31 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Spatial Working Memory (SWM)
The Spatial Working Memory test taxes the key
aspects of working memory: storage of
information over short periods of time and the
updating and manipulation of that information to
guide action. It also provides a measurement of
strategy use, thereby indexing executive
function in addition to working memory
capacity.
Description of the test
SWM measures the ability to retain spatial
information and manipulate it in working
memory. It is a self-ordered task that also
assesses the use of strategy.
Participants must search for blue tokens by
touching the coloured boxes to open them. The
critical instruction is that the participant must
not return to a box where a token has previously
been found. The task becomes more difficult as
the number of boxes increases.
Core outcomes
Key Outcome
Measures
Definition
Between errors The total number of times the subject revisits a box in which a token has
previously been found in the same
problem (calculated for assessed problems only)
Strategy For assessed problems with six boxes or more, the number of distinct boxes used by the subject to begin a new search for a
token, within the same problem
CANTAB Spatial Working Memory test
32 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Brain systems
Data from patients with brain lesions
demonstrates that SWM performance is
impaired by damage to the prefrontal cortex,
especially the dorsolateral prefrontal cortex
(Manes et al., 2002; Owen, Downes, Sahakian,
Polkey, & Robbins, 1990).
Versions of the task adapted for use in brain
scanning techniques have been used to shed
further light on the neural substrates mediating
SWM task performance. Positron emission
topography (PET) indicated that the dorsolateral
and mid-ventrolateral prefrontal cortices are
particularly recruited during task performance
(Figure 11: Mehta et al., 2000).
Figure 11. Control participants performing this task
show activation in the VLPFC and DLPFC
Pharmacology
Numerous studies have suggested that SWM
performance is sensitive to dopamine
manipulation. For example, SWM is impaired by
acute tyrosine depletion (Harmer, McTavish,
Clark, Goodwin, & Cowen, 2001), and improved
by D2 agonist administration (Mehta et al.,
2001). Furthermore, the stimulant
methylphenidate significantly improves SWM
performance in healthy volunteers as well as
various patient groups (Kempton et al., 1999;
Mehta et al., 2000; Turner et al., 2005). By
integrating imaging and pharmacological
approaches, it was found that dorsolateral
prefrontal cortex activation during SWM
performance is dependent on dopamine
modulation (Mehta et al., 2000).
This task has been used in a number of
pharmacological studies of patients. For
example, adults with ADHD show significantly
improved performance on SWM following
administration of methylphenidate but not
modafinil (Kempton et al., 1999; Turner et al.,
2005).
Ageing
Consistent with the protracted development of
the prefrontal cortex thorough childhood and
adolescence and its sensitivity to normal ageing,
performance on the SWM task shows both clear
developmental and ageing effects particularly in
the between-search errors index (Figure 12).
Figure 12: normative trajectory of performance in the
SWM task. Higher scores indicate worse performance
Sensitivity to impairment in clinical populations
Dementia and MCI
Alzheimer’s Disease
In addition to affecting episodic memory, AD
affects working memory, which is dependent on
frontal and temporal lobe structures. Patients
have been found to perform worse than healthy
controls on spatial working memory (Sahgal et
al., 1992). The pattern of performance is such
that there is a steep decrease in performance as
task difficulty increases in both AD and controls,
33 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
although AD performance is worse than that of
controls at all stages of the task (Figure 13). This
highlights the suitability of this test even in
cases with mild dementia, as performance does
not reach floor levels early on in the task.
Figure 13: Sahgal et al., 1992
Mild cognitive impairment
SWM contributes to discrimination of MCI from
normal ageing in combination with other
measures of memory, attention and executive
function (Klekociuk & Summers, Neurology,
2014).
Significant differences in working memory
capacity have been found between subgroups of
MCI, with those with a-MCI+ (amnestic MCI with
additional deficits in other domains) making
more errors than those with purely amnestic
MCI (Klekociuk & Summers 2014b; Saunders &
Summers 2011).
The strategy score also showed significant
differences between MCI sub-groups, with again
the a-MCI+ performing worse than the a-MCI
group. (Klekociuk & Summers 2014a). SWM
strategy scores were significantly higher at
baseline compared to 10 month and 20 month
follow-up periods (Saunders & Summers 2011).
Non-Alzheimer’s dementia
There is less data regarding the profile of
cognitive performance in other forms of
dementia. Nevertheless, there is some evidence
to suggest that working memory is impaired.
Rahman et al. (1999) used CANTAB to profile
the cognitive dysfunction of patients with frontal
variant fronto-temporal dementia (fvFTD).
Small groups of fvFTD and age-matched controls
(n=8 in each group) were compared on a
number of CANTAB tests: pattern and spatial
recognition, spatial span, spatial working
memory and set-shifting.
In this study, fvFTD subjects were relatively
unimpaired on the spatial working memory task,
although differences were found in more
complex CANTAB measures of executive
function.
However, Sahgal et al (1995) assessed
differences in cognitive profiles between
subjects with AD and those with dementia of the
Lewy Body type (DLB). They examined spatial
working memory in a small subset of their
sample (AD, n=8; DLB, n=8), and found a
differential pattern of errors. Control subjects
made the fewest between search errors,
followed by AD patients, and DLB patients made
the greatest. For within-search errors, DLB
patients were significantly impaired in
comparison with AD and controls (these two
groups did not differ). This differential pattern of
impairment on spatial working memory is
thought to reflect dysfunctions in non-mnemonic
processes mediated by fronto-striatal circuits,
which are more severely damaged in DLB.
Psychiatric and mood disorders
Depression
A recent meta-analysis of studies of depressed
participants which have used CANTAB showed
that there was a significant deficit in spatial
working memory, relative to controls. This
impairment was present even in unmedicated
and remitted participants (Rock et al., 2013),
suggesting that this is potentially an important
cognitive variable in depression.
34 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Schizophrenia
Cognitive Impairment Associated with
Schizophrenia (CIAS) is an important
determinant of functional outcome, and working
memory impairment is a core component of this.
Impairments have been seen across the range
of chronicity and severity of schizophrenia.
In hospitalised patients with chronic
schizophrenia, Pantelis et al. (1997) found
deficits in SWM relative to healthy controls. In
addition, comparison between patients with
schizophrenia and those with frontal lobe lesions
showed equivalent impairments on spatial
working memory, with increased between-
search errors. Patients with schizophrenia were
unable to develop a systematic strategy to
complete this task, relying instead on a limited
visuospatial memory span.
Elliot et al. (1998) considered
neuropsychological deficits in schizophrenic
patients with preserved intellectual function (IQ
>90) in order to examine the specificity of their
cognitive impairment independent of global
decline. On Spatial Working Memory, the
patients showed impairment on both mnemonic
and strategic components of the task, in
contrast to temporal lobe patients (mnemonic
impairment only) and frontal lobe patients
(strategic impairment only) (Owen et al, 1995).
Thus the data presented in this study confirm
the many previous findings of mnemonic and
executive dysfunction in schizophrenia, but do
not suggest primacy of one over the other.
Deficits are present even earlier in the course of
the disease, before the cumulative effects of
medication have had an impact. Hutton et al.
(1998) researched executive function in first-
episode schizophrenia in 30 patients and 30
healthy volunteers matched for age and NART
IQ. Patients with schizophrenia showed the
greatest impairments on tests of executive
functioning, including SWM.
The potential importance of SWM in the
cognitive phenotype of schizophrenia is
highlighted in a study of patients before the
onset of diagnosed schizophrenia. Wood et al.
(2003) explored the relationship between
working memory and negative symptoms in
patients who had been referred to the Personal
Assessment and Crisis Evaluation Clinic,
Melbourne, Australia, as being at high risk of
developing psychosis. There were 38 high risk
patients (9 of which later become psychotic at
least 12 months from baseline assessment) and
49 healthy controls. The high risk group
performed significantly more poorly than the
healthy controls, and those who went on to
develop psychosis performed more poorly than
those who did not, but this did not reach
significance. However, for the group that went
on to develop psychosis, there was a significant
association between their SWM errors score and
their total score on the Scale for Assessment of
Negative Symptoms.
Neurological and movement disorders
Parkinson’s Disease
SWM performance is impaired in Parkinson’s
disease (Owen et al., 1997, 1992). This
impairment is thought to be driven by
dopaminergic dysfunction in PD. L-dopa
withdrawal impairs SWM task performance in
patients with Parkinson’s disease (
35 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Figure 14: Lange et al., 1992). Neuroimaging
evidence suggests that the beneficial effect of L-
dopa is mediated by improved efficiency in the
dorsolateral prefrontal cortex (Cools, Stefanova,
R. Barker, Robbins, & Owen, 2002).
Figure 14: L-dopa withdrawal impairs spatial working
memory in patients with Parkinson’s disease (Lange et
al., 1992).
Multiple sclerosis
SWM performance has been found to be
impaired in patients with multiple sclerosis
relative to controls (
Figure 15: Foong et al., 2000; Foong et al.,
1997). Furthermore, performance at the more
difficult 6-box and 8-box stages of this task
correlated significantly with frontal lobe lesion
load determined using MRI in patients with
multiple sclerosis (Foong et al., 1997), again
indicating the sensitivity of this measure to
frontal lobe impairments.
Figure 15: Patients with multiple sclerosis show
impaired spatial working memory relative to controls
at all levels of difficulty (Foong et al., 1997).
Traumatic Brain Injury
Sterr et al. (2006) showed a trend for poorer
CANTAB SWM performance in patients with
symptomatic TBI relative to non-symptomatic
TBI patients and healthy controls. Performance
on CANTAB SWM was significantly associated
with symptom severity. A study by McAllister et
al. (2001) showed that TBI patients
demonstrate different activation patterns of
working memory circuitry on fMRI relative to
healthy controls. A further review by McAllister
(2006) suggests that patients with TBI have
problems in the activation and allocation of
working memory, and that these may be
secondary to reduced catecholaminergic
function.
ADHD
Both individual studies (e.g. (Kempton et al.,
1999; McLean et al., 2004), and meta-analysis
(Chamberlain et al., 2011), have shown
extensive impairments in spatial working
memory in ADHD. These are evident both in
terms of between-search errors and strategy
scores.
Methylphenidate significantly improves
performance on SWM in children and adults with
ADHD as well as in healthy volunteers (Kempton
et al., 1999; Mehta et al., 2004, 2000; Turner et
al., 2005).
Off
On
36 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
References • Chamberlain, S. R., Robbins, T. W., Winder-
Rhodes, S., Müller, U., Sahakian, B. J.,
Blackwell, A. D., & Barnett, J. H. (2011).
Translational approaches to frontostriatal
dysfunction in attention-deficit/hyperactivity
disorder using a computerized
neuropsychological battery. Biological
psychiatry, 69(12), 1192-1203.
• Cools, R., Stefanova, E., Barker, R. A.,
Robbins, T. W., & Owen, A. M. (2002).
Dopaminergic modulation of high‐level
cognition in Parkinson’s disease: the role of
the prefrontal cortex revealed by
PET. Brain, 125(3), 584-594.
• Elliott, R., McKenna, P. J., Robbins, T. W., &
Sahakian, B. I. (1998). Specific
neuropsychological deficits in schizophrenic
patients with preserved intellectual function.
Cognitive Neuropsychiatry, 3(1), 45-69.
• Foong, J., Rozewicz, L., Chong, W. K.,
Thompson, A. J., Miller, D. H., & Ron, M. A.
(2000). A comparison of neuropsychological
deficits in primary and secondary progressive
multiple sclerosis. Journal of
neurology, 247(2), 97-101.
• Foong, J., Rozewicz, L., Quaghebeur, G.,
Davie, C. A., Kartsounis, L. D., Thompson, A.
J., Miller, D. H. & Ron, M. A. (1997). Executive
function in multiple sclerosis. The role of
frontal lobe pathology. Brain, 120(1), 15-26.
• Harmer C.J., McTavish S.F.B., Clark L.,
Goodwin G.M., Cowen P.J., (2001) Tyrosine
depletion attenuates dopamine function in
healthy volunteers, Psychopharmacology,
154, 105-111
• Hutton SB, Puri BK, Duncan L-J, Robbins TW,
Barnes TRE and Joyce EM (1998) Executive
function in first-episode schizophrenia.
Psychological Medicine, 28, 463-473.
• Kempton, S., Vance, A., Maruff, P., Luk, E.,
Costin, J., & Pantelis, C. (1999). Executive
function and attention deficit hyperactivity
disorder: stimulant medication and better
executive function performance in children.
Psychological medicine, 29(3), 527-538.
• Klekociuk, S. Z., & Summers, M. J. (2014a).
Exploring the validity of mild cognitive
impairment (MCI) subtypes: Multiple-domain
amnestic MCI is the only identifiable subtype
at longitudinal follow-up. Journal of Clinical
And Experimental Neuropsychology, 36(3),
290-301.
• Klekociuk, S. Z., & Summers, M. J. (2014b).
Lowered performance in working memory and
attentional sub‐processes are most prominent
in multi‐domain amnestic mild cognitive
impairment subtypes. Psychogeriatrics,
14(1), 63-71.
• Klekociuk, S. Z., & Summers, M. J. (2014c).
The learning profile of persistent mild
cognitive impairment (MCI): a potential
diagnostic marker of persistent amnestic MCI.
European Journal of Neurology, 21(3), 470-
e24.
• Lange, K. W., Robbins, T. W., Marsden, C. D.,
James, M., Owen, A. M., & Paul, G. M. (1992).
L-dopa withdrawal in Parkinson's disease
selectively impairs cognitive performance in
tests sensitive to frontal lobe dysfunction.
Psychopharmacology, 107(2-3), 394-404.
• Manes, F., Sahakian, B., Clark, L., Rogers, R.,
Antoun, N., Aitken, M., & Robbins, T. (2002).
Decision‐making processes following damage
to the prefrontal cortex. Brain, 125(3), 624-
639.
• McAllister, T. W., Flashman, L. A., McDonald,
B. C., & Saykin, A. J. (2006). Mechanisms of
working memory dysfunction after mild and
moderate TBI: evidence from functional MRI
and neurogenetics. Journal of neurotrauma,
23(10), 1450-1467.
• McAllister, T. W., Sparling, M. B., Flashman,
L. A., Guerin, S. J., Mamourian, A. C., &
Saykin, A. J. (2001). Differential working
memory load effects after mild traumatic
brain injury. Neuroimage, 14(5), 1004-1012.
• McLean, A., Dowson, J., Toone, B., Young, S.,
Bazanis, E., Robbins, T. W., & Sahakian, B. J.
(2004). Characteristic neurocognitive profile
37 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
associated with adult attention-
deficit/hyperactivity disorder. Psychological
medicine, 34(04), 681-692.
• Mehta, M. A., Goodyer, I. M., & Sahakian, B.
J. (2004). Methylphenidate improves working
memory and set‐shifting in AD/HD:
relationships to baseline memory
capacity. Journal of Child Psychology and
Psychiatry, 45(2), 293-305.
• Mehta, M. A., Owen, A. M., Sahakian, B. J.,
Mavaddat, N., Pickard, J. D., & Robbins, T. W.
(2000). Methylphenidate enhances working
memory by modulating discrete frontal and
parietal lobe regions in the human brain. J
Neurosci, 20(6), RC65.
• Mehta, M. A., Sahakian, B. J., & Robbins, T.
W. (2001). Comparative psychopharmacology
of methylphenidate and related drugs in
human volunteers, patients with ADHD, and
experimental animals. Stimulant drugs and
ADHD: Basic and clinical neuroscience, 303-
331.
• Owen, A. M., Downes, J. J., Sahakian, B. J.,
Polkey, C. E., & Robbins, T. W. (1990).
Planning and spatial working memory
following frontal lobe lesions in man.
Neuropsychologia, 28(10), 1021-1034.
• Owen, A. M., Iddon, J. L., Hodges, J. R.,
Summers, B. A., & Robbins, T. W. (1997).
Spatial and non-spatial working memory at
different stages of Parkinson's
disease. Neuropsychologia, 35(4), 519-532.
• Owen, A. M., James, M., Leigh, P. N.,
Summers, B. A., Marsden, C. D., Quinn, N. P.,
Lange, K. W. & Robbins, T. W. (1992). Fronto-
striatal cognitive deficits at different stages of
Parkinson's disease. Brain, 115(6), 1727-
1751.
• Owen, A. M., Sahakian, B. J., Semple, J.,
Polkey, C. E. and Robbins, T. W. (1995) Visuo-
spatial short-term recognition memory and
learning after temporal lobe excision, frontal
lobe excision or amygdalo-hippocampectomy
in man. Neuropsychologia, 33, 1-24.
• Pantelis, C., Barnes, T.R.E., Nelson, H.E.,
Tanner, S., Weatherly, L., Owen, A.M. and
Robbins, T.W. (1997). Frontal-striatal
cognitive deficits in patients with chronic
schizophrenia. Brain, 120, 1823-1843.
• Rahman, S., Sahakian, B. J., Hodges, J. R.,
Rogers, R. D., & Robbins, T. W. (1999).
Specific cognitive deficits in mild frontal
variant frontotemporal
dementia. Brain, 122(8), 1469-1493.
• Rock, P. L., Roiser, J. P., Riedel, W. J., &
Blackwell, A. D. (2013). Cognitive impairment
in depression: a systematic review and meta-
analysis. Psychological medicine, 1-12.
• Sahgal, A., Galloway, P. H., McKeith, I. G.,
Lloyd, S., Cook, J. H., Ferrier, I. N., &
Edwardson, J. A. (1992). Matching-to-sample
deficits in patients with senile dementias of
the Alzheimer and Lewy body types. Archives
of neurology, 49(10), 1043-1046.
• Sahgal, A., McKeith, I. G., Galloway, P. H.,
Tasker, N., & Steckler, T. (1995). Do
differences in visuospatial ability between
senile dementias of the Alzheimer and Lewy
body types reflect differences solely in
mnemonic function?. Journal of clinical and
experimental neuropsychology, 17(1), 35-43.
• Saunders, N. L., & Summers, M. J. (2011).
Longitudinal deficits to attention, executive,
and working memory in subtypes of mild
cognitive impairment. Neuropsychology,
25(2), 237.
• Sterr, A., Herron, K. A., Hayward, C., &
Montaldi, D. (2006). Are mild head injuries as
mild as we think? Neurobehavioral
concomitants of chronic post-concussion
syndrome. BMC neurology, 6(1), 7.
• Turner, D. C., Blackwell, A. D., Dowson, J. H.,
McLean, A., & Sahakian, B. J. (2005).
Neurocognitive effects of methylphenidate in
adult attention-deficit/hyperactivity
disorder. Psychopharmacology, 178(2-3),
286-295.
• Wood, S.J., Pantelis, C., Proffitt, T., Phillips.
L.J., Stuart, G.W., Buchanan, J.-A, Mahony,
K., Brewer, W., Smith, D.J. and McGorry, P.D.
(2003). Spatial working memory ability is a
marker of risk-for-psychosis. Psychological
Medicine, 33, 1239-1247.
38 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Cognitive testing – test recommendation by disease
39 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Cognitive testing – test recommendation by disease
40 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
40 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Cognitive testing: quality consideration
Characterising cognition depends on the
reliability of the measures used. Reliability of
cognitive testing is increased by reducing
sources of error or bias in measurement. There
are several potential sources of error which
computerised cognitive testing address:
• Reducing errors of measurement. In
standardised pencil and paper tests, reliability
depends on highly skilled administrators to
accurately record responses, measure
reaction times and then code, record and
score the responses. Errors at each stage of
this process can impact reliability.
Computerised assessment interfaces directly
with the participant and automates these
processes, reducing potential errors.
• Lengthier tasks can increase reliability by
administering more trials. However, in
populations such as children, and those with
cognitive impairment, these additional trials
increase testing time and place additional
burdens on sustained attention. This may
paradoxically reduce reliability when
participants’ attention wanes or they tire.
Computerised assessment provides short
forms of tasks allowing appropriate testing
time for the study population.
• The ability to implement tasks in which the
condition or stimuli presented depends on
participants’ previous responses is a further
advantage, again reducing testing time, and
maintaining participant engagement.
• In populations such as Parkinson’s disease or
normal ageing, difficulties with motor control
can also introduce measurement error and
reduce participant’s ability to comply with
testing. The use of intuitive and well-designed
interfaces can facilitate this. Research has
shown that computerized cognitive testing is
acceptable to elderly participants, often being
better tolerated than pencil-and paper
assessments (Fillitt et al., 2008; Collerton et
al., 2008)
In addition to the reliability of measurement,
another key requirement of cognitive tests is
their sensitivity to impairment and to change
over time. Computerised cognitive testing can
optimise this in a number of ways:
• Floor or celling effects limit the ability to
detect change or differences in scores,
particularly in very able or impaired samples.
Adaptive algorithms, which alter presentation
of stimuli dependent on previous
performance, can prevent this.
• The provision of parallel forms and the
presentation of random stimuli to enable tasks
to be repeated over time can increase
sensitivity to longitudinal change by
minimising practice effects (Semple & Link,
1991; Louis et al., 1999).
Extensive published data from intervention
studies allows study-specific estimates of effect
size to be generated, which will ensure studies
are adequately powered to detect differences.
References • Collerton J, Collerton D, Arai Y, Barrass K,
Eccles M, Jagger C, McKeith I, Saxby BK,
Kirkwood T; Newcastle 85+ Study Core Team
(2007). A comparison of computerized and
pencil-and-paper tasks in assessing cognitive
function in community-dwelling older people
in the Newcastle 85+ Pilot Study. J Am Geriatr
Soc.; 55(10):1630-5.
• Fillitt HM, Simon ES, Doniger GM, Cummings
JL. Practicality of a computerized system for
cognitive assessment in the elderly.
Alzheimer's and Dementia. 2008;4:14–21
• Louis, W. J., Mander, A. G., Dawson, M.,
O'Callaghan, C., & Conway, E. L. (1999). Use
of computerized neuropsychological tests
(CANTAB) to assess cognitive effects of
antihypertensive drugs in the elderly. Journal
of hypertension, 17(12), 1813-1819.
• Semple, J., & Link, C. G. G. (1991). CANTAB
Parallel Battery: a suitable tool for
investigating drug effects on cognition. In Soc
Neurosci Abstr (Vol. 273, No. 2).
41 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Study Practicalities Does it matter if my subject is
colour blind?
Most of the tests can be administered if the
subject is colour blind. For example, PAL has
unique patterns that are independent of colour,
so scores on these tasks should not be affected.
In the DMS, however, subjects need to be able
to differentiate colours. However, the results
would only be affected in severe cases of colour
blindness, which are quite rare.
We would suggest doing a very quick screen for
colour blindness with a subject on the first
testing session using the Ishihara Colour Test.
Alternatively, the practice stages on each task
can be used to ensure the subjects can
differentiate the colours used.
Can I use CANTAB with people with limited cognitive functioning?
This depends on the level of impairment. The
advantage of CANTAB is that the majority of the
tasks are language and culture independent,
and the tasks have an intuitive game-like quality
ideal for testing in populations with limited
mental capabilities. The CANTAB tasks have
been used in individuals from specific disease
populations that are characterised by very
limited cognitive functioning, for example,
Alzheimer’s disease. The normative database
includes children as young as four and adults
over the age of 90.
Can I use CANTAB with people with physical disabilities?
This depends on the type and level of physical
disability. To determine whether a subject can
complete CANTAB, we recommend the
completion of the MOT task for screening
purposes. This task simply involves the subject
touching crosses that appear on the touch
screen. From performance on this task, we can
assess any problems with vision, motor control
or comprehension that may result in the subject
being unable to complete the remaining CANTAB
tests.
What if the subject refuses to finish the test?
The majority of CANTAB tests are graded in
difficulty and designed to terminate prematurely
when a subject reaches their cognitive limit. By
setting the subjects expectations and providing
reassurance and encouragement, a subject
should always be able to complete the tests.
Some examples of positive encouragement that
can be used to motivate a subject to continue
are as follows:
“Well done, this test is very hard, you are doing
well.”
“Not long to go; you have nearly finished this
test.”
If the subject refuses to complete the test,
despite encouragement, then please use the
abort function.
If a test is aborted, we would recommend you
record a comment at the end of the testing
session. The comment should explain the
situation, mention that the subject refused to
continue, any specific reasons why and which
particular tests were not attempted or aborted.
This is very useful when reviewing data.
Cambridge Cognition does not recommend that
aborted data is included for analysis, and our
normal internal procedure is to remove these
test runs.
What if I need to rerun the test?
If you needed to abort a test during a testing
session, e.g. because of a fire alarm, then you
should rerun the test as soon as possible.
42 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
Can data from aborted tests be
used?
We would recommend that data from aborted
CANTAB test runs is excluded from the final
dataset and not include in the analysis.
The psychometric validity of data could be
significantly altered by aborting a test. To
provide consistency across sites and raters it is
extremely important that the CANTAB tests are
run in full. The majority of the tests are graded
in difficulty and designed to terminate
prematurely when a subject reaches their
cognitive limit, therefore there should be no
need to abort manually. For example, in the PAL
task, if the subject fails to recall all of the
locations correctly after a set number of
attempts the test will terminate. By following the
script, setting the subjects expectations and
providing reassurance and encouragement, it
should not be necessary to abort a test.
If an individual test is aborted in a test battery,
then all data from fully completed tests in the
session can still be included in the analysis.
Can I allow breaks during CANTAB sessions?
We would recommend you allow breaks during
the CANTAB sessions, depending on the length
of the testing period, providing that the breaks
are between tests and not during a test.
It is best practice to keep the breaks consistent
so that they occur at the same point in the
testing session for all subjects. However, this is
not always practical and additional breaks may
be given as and when required.
Can I allow food, drinks, and
cigarettes during CANTAB testing?
CANTAB tests are very sensitive, and differences
in CANTAB task performance have been
demonstrated from everyday substances, such
as the amount of caffeine contained in one cup
of tea. Cigarettes and certain foods have also
been demonstrated to influence performance.
Therefore we would advise that food, drinks and
cigarettes are not allowed during the CANTAB
testing period. Water may be given if needed.
43 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
Data analysis considerations
The analysis of cognitive variables raises a
variety of statistical issues, and the aim of this
section is to address some of these issues and
provide guidance when writing a statistical
analysis plan prior to the study. Naturally, it is
not expected that the recommendations made
below will be appropriate in all cases, and it is
strongly recommended that you seek specialist
statistical advice.
However, it is hoped that by following the
recommendations contained within this
document, statistical analyses performed on
CANTAB data will be both readily interpretable
and performed according to valid statistical
principles.
Checklist
This checklist gives a number of important
things that you should consider at the study
design stage:
• Have you considered sample size and
statistical power for the study?
• If you are planning to use composite
measures in the study, have you discussed
their construction with a statistician?
• Which factors do you plan to use as
covariates?
• Are you planning one-tailed or two-tailed
tests?
• How will you assess whether the assumptions
of parametric analysis have been met and
what are the alternative tests to be used
should these assumptions not be met?
• Have you discussed the procedures for dealing
with missing data with a statistician?
Power Calculations
The specific power calculation you need will
depend on whether you have a between-
subjects design (e.g. difference between two
independent means) or within-subjects design
(difference between two dependent means e.g.
from matched pairs).
We recommend that you power using two-
tailed testing with an alpha of 0.05 (probability
of false alarm) and a power of 0.8.
To help, below is a table of power calculations,
which is for between-subjects design. By
Cohen’s definition, an effect size of 0.2 is
considered small, an effect size of 0.5 is
considered medium and an effect size of 0.8 is
considered large.
Table 1: Power calculation table
Tails Power Alpha Effect size N1 N2
Two 0.80 0.05 0.2 394 394
Two 0.80 0.05 0.5 64 64
Two 0.80 0.05 0.8 26 26
Two 0.80 0.1 0.2 310 310
Two 0.80 0.1 0.5 51 51
Two 0.80 0.1 0.8 21 21
One 0.80 0.05 0.2 310 310
One 0.80 0.05 0.5 51 51
One 0.80 0.05 0.8 21 21
One 0.80 0.1 0.2 226 226
One 0.80 0.1 0.5 37 37
One 0.80 0.1 0.8 15 15
Data preparation
Before commencement of statistical analysis, it
is always recommended that the data are
inspected and, if necessary, transformed such
that appropriate statistical tests are employed
for a given cognitive measure. Note that it is
likely that different transformations will be
necessary for different measures, and in general
the procedures below ought to be performed on
a variable-by-variable basis.
Non-normality, skew and kurtosis
As discussed below, it is usually preferable to
employ parametric statistics for the analysis of
cognitive measures, since they provide a
number of advantages over non-parametric
statistics. Analysing raw data (e.g., percent
correct, reaction time) provides the most readily
interpretable results from parametric analysis.
44 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
However, for many cognitive outcome variables
the raw data will be skewed, and therefore not
suitable for analysis with parametric tests,
which, assuming a relatively low number of data
points, only produce accurate results if data are
normally distributed. This is particularly
common for reaction time measures, where a
few slow subjects may lengthen the right hand
tail of the distribution (i.e. positive skew), or
accuracy measures on easy stages of tests
where most subjects perform very well but a few
inaccurate scores may lengthen the left hand tail
of the distribution (i.e. negative skew).
The preferred method to detect skew is to plot
the residuals from the statistical analysis, for
example using a box and-whisker plot, and the
statistician should use their judgment and
experience in this matter. However, since
skewed raw data will generally result in skewed
residuals, it may be possible to detect skew in
the raw data. Kurtosis is a measure of whether
the data are peaked or flat relative to a normal
distribution. Data sets with high kurtosis
(leptokurtic) tend to have a distinct peak near
the mean, decline rather rapidly, and have
heavy tails. Data sets with low kurtosis
(platykurtic) tend to have a flat top near the
mean rather than a sharp peak. A normal
distribution is said to be mesokurtic.
If significant skew or kurtosis is detected, a
transformation may render the data suitable for
parametric analysis. However, it is vital to
choose an appropriate transform for a given
outcome measure, since inappropriately
transforming data might either reduce
sensitivity or increase the chance of spurious
results.
The transformation is dependent on the nature
of the skew, and detailed advice should be
sought. As a general rule, for positively skewed
data a log transformation is recommended,
while a square transform may be able to correct
for negative skew. However, it should be noted
that transformation will change the nature of the
treatment estimates produced from parametric
analysis. For example, if a log transform has
been employed, the treatment estimates will
represent the ratio of one group’s score to that
of another group, and not differences in the
original cognitive measure.
Following transformation, the residuals from
statistical analysis and/or raw data should be
inspected to confirm that the skew has been
removed successfully. In some cases it may not
be possible to produce a normal distribution by
transformation, and non-parametric analyses
will be necessary (see below).
If using a regression to analyse data, it is the
normality of the residuals (in relation to
predictors) that is required, rather than
normality of the raw scores. In these cases, and
assuming an adequate sample size, it may be
that removing extreme outliers (i.e.
standardised residuals > +3 / -3) enables this
assumption to be met.
Including covariates in an analysis
In general, the covariates to be included in the
general linear model should be detailed in the
analysis plan prior to statistical analysis. It is
recommended that variables such as test site
and cognitive battery order are entered as
random-effects to conserve degrees of freedom
and improve sensitivity, while demographic
variables such as age, IQ and gender should be
entered as fixed-effects. In a repeated measures
design, if baseline scores are available for each
cognitive outcome variable of interest, baseline
score can also be entered as a fixed-effect.
Many studies, for example in pharmaceutical
trials, employ longitudinal designs, where
subjects are tested at repeated time-points
following the commencement of drug treatment.
In such cases, it is strongly recommended that
a repeated measures mixed-model is used. This
is the most sensitive method to determine
whether a drug starts to have a beneficial effect
at a particular time-point following treatment,
and can also be helpful in dealing with missing
data. Where appropriate, an autoregressive
function should be included to account for
correlations between measures taken at
successive time-points. It may also be useful to
include a drug treatment x time interaction term
45 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
in the model. However, the exact nature of the
longitudinal model to be employed should be
discussed with a statistician. In some cases,
absolute differences between treatment groups
may provide the most meaningful interpretation
of the data. In other cases, change-from-
baseline scores may be most informative. In the
case where change-from-baseline score is
preferred, it is still recommended to include
baseline score as a covariate in the analysis to
provide maximum sensitivity. This may seem
counter-intuitive, since using a change-from-
baseline measure effectively already includes
the baseline term in the model. However, on
many cognitive outcome measures, it is possible
that both the change-from-baseline score and
the post-treatment score may covary with the
baseline score due to boundary effects. In such
cases, including the baseline score will improve
sensitivity by accounting for extra error variance
in the analysis.
Composite measures
A number of approaches have been taken with
respect to the generation of composite
measures. In general, it is advisable to discuss
the construction of composite measures prior to
the commencement of the study. Composite
measures can be useful, since they may provide
greater sensitivity than individual test results by
providing a more precise estimate of an
underlying cognitive process. Furthermore,
composite measures can reduce the number of
primary end-points in a trial, thus at least
partially circumventing the issue of multiple
comparisons. However, in some cases, a
particularly focused cognitive measure will prove
a more sensitive index than composite
measures.
If it is intended that composite measures are
employed, it is vital that the method of
calculating the composite measure is considered
prior to data collection. Furthermore, it is
strongly recommended that only those
composite measures based on published factor
analyses that have previously been validated
should be employed. If composite measures are
calculated without using reference to
established methods, the results may be difficult
to interpret, since a change in the composite
measure cannot be compared to other published
studies. This makes the magnitude of a given
change in a composite measure considerably
more difficult to interpret with respect to
previous literature. Factor analyses of CANTAB
scores in large datasets have been published
(e.g., Robbins et al., 1994; see also Harrison et
al., 2007 for non- CANTAB tests), and should
can be examined for guidance and to guide the
analysis strategy.
Test-retest reliability
Technically, reliability measurement is an
attempt to estimate the measurement error
attached to the use of a test or instrument.
When applied to psychological tests, reliability
most often relates to either the internal
consistency (do items in the test measure the
‘same thing’) or to temporal consistency. The
latter form is referred to as ‘Test-Retest
Reliability’ and is most often reported as the
degree of correlation between first test and
retest performance.
A number of studies have published test-retest
reliabilities in healthy volunteers and patients.
• Lowe and Rabbitt (1998) assessed 4-week
test-retest reliability from 162 healthy
volunteers:
• Delayed matching to sample (DMS) number
correct r=0.56
• Paired associates learning (PAL) first trial
memory score r=0.68, average trials to
success r=0.86
• Spatial working memory (SWM) total errors
r=0.68
Leeson and colleagues (2009) assessed test-
retest reliability over 1 and 2 years within 25
healthy volunteers and 104 patients with
schizophrenia:
• Spatial working memory (SWM) between
errors: healthy volunteer 56-week r=0.52,
66-week r=0.65; schizophrenia 74-week
r=0.62, 100-week r=0.62; strategy: healthy
volunteer 56-week r=0.54, 66-week r=0.60;
46 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
schizophrenia 74-week r=0.40, 100-week
r=0.57
• Fowler and colleagues (1995) assessed 1-
month test-retest reliability in healthy
volunteers, patients with questionable
dementia and patients with Alzheimer’s
disease:
• Delayed matching to sample (DMS) number
correct (12-second delay): healthy volunteers
r=0.52, questionable dementia r=0.57,
Alzheimer’s disease r=0.84
• Paired associates learning (PAL) total errors:
healthy volunteers r=0.64, questionable
dementia r=0.71, Alzheimer’s disease r=0.88
Barnett and colleagues’ (2010) review outlines
3-month test-retest reliability in patients with
schizophrenia:
• Spatial working memory (SWM) between
errors 12-week r=0.65, 14-week r=0.83;
strategy 12-week r=0.75, 14-week r=0.75
Furthermore, Harrison and colleagues’
unpublished manuscript assessed test-retest
reliability over 1-8 weeks in 100 healthy
volunteers:
• Delayed matching to sample (DMS) number
correct r=0.50
• Paired associates learning (PAL) stages
completed r=0.87, total errors r=0.68
• Reaction time (RTI) simple RT r=0.54, 5-
choice RT r=0.57, movement time r=0.73
• Rapid visual information processing (RVP)
total hits r=0.64, latency r=0.64
• Spatial working memory (SWM) between
errors r=0.70, strategy r=0.63
Change in individual’s
performance - measurement
error or ‘real effect’?
One consequence of using a correlation
coefficient as a reliability measure is that a
uniform change in performance across a group
will yield a high correlation coefficient, even
though subjects may have improved or declined
by the same rate. With psychometric measures
there appears to be a high a priori expectation
that performance will necessarily improve with
repeated administrations of the test.
Improvements in performance as a result of
repeated exposure may be due to the adoption
of a strategy. In circumstances such as these,
changes in performance can be viewed as due to
a real effect, rather than simply due to
measurement error.
The foregoing discussion raises a number of
issues for examining the Test-retest reliability
(TRR) of the CANTAB system outcome
measures. The first challenge is to calculate TRR
correlation coefficients for each of the outcome
measures and then to determine whether retest
performance improves, deteriorates, or remains
the same when compared to first test scores.
Changes in group performance can be
determined by testing for the presence of a
significant change between test and retest.
However, most often one is seeking to
determine whether an individual’s change in
performance is due to a real effect or to
measurement error.
When assessing the performance of an
individual at retest, it is useful to know whether
any change associated with retest performance
is due to a real effect (e.g. due to physical
degeneration [a worsening of performance] or
due to practice or recovery [an improvement]).
The standard errors of prediction reported in
Table 2 can be used to determine this as they
can be used to calculate a confidence interval for
retest performance. If the retest performance
score falls within the upper and lower bounds of
this confidence interval, then retest change can
be judged to be due to measurement error.
Scores beyond the confidence interval bounds
are likely to be due to the influence of a real
effect. This decision is subject to the usual twin
statistical hazards of making type 1 and type 2
errors. When deciding whether retest change is
due to measurement error or a real effect, the
decision is biased toward rejecting the
hypothesis that the change is due to
measurement error. Consequently, we would
suggest that only scores falling within 66%
confidence intervals be interpreted as being
likely to be due to measurement error.
47 The CANTAB Cognition Handbook
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com ©Cambridge Cognition
A step-by-step procedure for determining
whether an individual’s retest change is due to
error or effect is described below.
Step 1
The vast majority of statistical techniques
assume that observations are independent.
Measures obtained from the same subject, even
on vastly different occasions, are clearly not
independent. For this reason, techniques have
been devised to allow for the calculation of ‘true
scores’ for which an allowance has been made
for measurement error and the score actually
obtained for a subject. Brophy (1986) describes
the following equation:
T = M + r(X-M)
where X is the obtained score, M is the mean of
the scores on the test and r is the reliability
coefficient of the test.
Step 2
Calculate the standard error of the ‘true’ score
obtained from step 1, using the appropriate SEP
from table 2 to plot the appropriate confidence
interval.
Step 3
Determine whether the retest scores falls within
or beyond the confidence interval calculated in
step 2 - scores falling within the CI can be
judged to be due to change consistent with
measurement error. Scores beyond the CI limits
are likely to be due to a real effect.
References • Barnett, J.H., Robbins, T.W., Leeson, V.C.,
Sahakian, B.J., Joyce, E.M., Blackwell, A.D.
(2010) Assessing cognitive function in clinical
trials of schizophrenia. Neuroscience and
biobehavioral reviews 34: 1161–77.
• Brophy, A.L. (1986) Confidence Intervals for
True Scores and Retest Scores on Clinical
Tests. Journal of Clinical Psychology, 42(6),
989-991.
• Fowler, K.S., Saling, M.M., Conway, E.L.,
Semple, J.M., Louis, W.J. (1995).
Computerized delayed matching to sample
and paired associate performance in the early
detection of dementia. Applied
Neuropsychology 2: 72–78
• Harrison, J.E., Iddon, J.L., Stow, I.A.,
Blackwell, A.D., Jefferies, M.C., Shah, P.P.,
(2007). Cambridge Neuropsychological Test
Automated Battery (CANTAB): Test-Retest
Reliability Characteristics. Unpublished.
• Leeson, V. C., Robbins, T. W., Matheson, E.,
Hutton, S. B., Ron, M. A., Barnes, T. R., &
Joyce, E. M. (2009). Discrimination learning,
reversal, and set-shifting in first-episode
schizophrenia: stability over six years and
specific associations with medication type and
disorganization syndrome. Biological
psychiatry, 66(6), 586-593.
• Lowe C, Rabbitt P (1998) Test/re-test
reliability of the CANTAB and ISPOCD
neuropsychological batteries: theoretical and
practical issues. Cambridge
Neuropsychological Test Automated Battery.
International Study of Post-Operative
Cognitive Dysfunction. Neuropsychologia 36:
915–23
• Robbins, T.W., James, T., Owen, A.M.,
Sahakian, B.J., McInnes, L. & Rabbitt, P.M.
(1994) CANTAB: A Factor Analytic Study of a
Large Sample of Normal Elderly Volunteers.
Dementia, 5, 266-281.
48 The CANTAB Cognition Handbook ©Cambridge Cognition
© Cambridge Cognition Limited 2018. All rights reserved.
www.cantab.com
UK office
Cambridge Cognition
Tunbridge Court
Bottisham
Cambridge
CB25 9TU United Kingdom
Cambridge Cognition
+44 (0)1223 810 700